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 Abstract 
 
  Obesity is rapidly increasing in prevalence, and has become one of the 
leading contributors to poor health in the world. Increased body weight by necessity 
must be a result of increased nutrient intake relative to total energy expenditure. 
While many have focused on the importance of caloric consumption in determining 
weight, it is increasingly clear that differences in energy expenditure, basal metabolic 
rates and/or adaptive thermogenesis are also important variables that contribute to 
human obesity.  
The experiments in this thesis start off by demonstrating that a significant 
portion of leptin-mediated weight loss is the result of an increase in energy 
expenditure caused by the hormone. They then go on to take a closer look at three 
candidate organs in which such changes in caloric expenditure are likely to be 
occurring. Our study finds that leptin treatment of ob/ob mice reduces the basal 
metabolic rate, uncoupled respiration (i.e. leak), and non-mitochondrial respiration of 
primary hepatocytes. We show that this is due to changes in the substrate oxidation 
system in liver mitochondria as well as changes in mitochondrial structure, and 
volume density. These changes are directly caused by leptin, and are not downstream 
of the hormone’s correction of hepatic steatosis. 
We next explored the proteomic and lipidomic modifications underlying the 
changes discussed above. Leptin-mediated changes in three components of the 
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mitochondrial respiratory chain can account for the aforementioned metabolic effects 
of the hormone in the liver. Dramatic alterations in levels of the enzyme ELOVL5 
might be responsible for the hepatic steatosis exhibited with leptin deficiency, and for 
its correction with leptin treatment. Furthermore, differences in mitochondrial 
cardiolipin levels may also be associated with the observed leptin-mediated changes 
in the liver. Finally, we show a trend that leptin may be altering the levels of reactive 
oxygen species in hepatic mitochondria. 
Having completed a thorough investigation into leptin-mediated changes in 
the liver, we moved on to the other two candidate organs, the heart and skeletal 
muscle. Our results show that leptin clearly modulates mitochondrial respiration in 
these tissues, though we cannot yet say exactly how it does so. In conclusion, this 
thesis illustrates the effects of leptin levels on the liver, and details the mechanisms 
by which the hormone induces change down to the proteomic level. It also shows 
clear leptin-mediated effects in skeletal muscle and the heart, and sets the stage for 
further investigation into the role of these tissues in leptin induced weight loss. 
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 Chapter 1: Introduction 
Obesity as a Global Health Problem 
 
Defining Obesity and the Associated Physical and Psychological Stress 
Obesity is loosely defined as an excess amount of body fat relative to lean 
body mass. The most commonly used method for categorizing individuals as being 
overweight or obese is body mass index (BMI), which is calculated by dividing one’s 
weight in kilograms by the square of his/her height in meters. Waist circumference, 
skin fold thickness, and bioimpedance are other methods used in defining obesity. 
The World Health Organization defines individuals with BMIs over 25 as being 
overweight, and those with a BMI over 30 as obese (Committee, 1995; W.H.O., 
1997). 
 Obese individuals are at a higher risk for developing coronary heart disease, 
type 2 diabetes mellitus, hypertension, cancer, strokes, sleep apnea, cholelithiasis, and 
osteoarthritis (Bennett, 1996; Kopelman, 2000). Studies have shown a positive 
correlation between mortality and body weight, with the lowest mortality being found 
in those who are slightly underweight (Lew, 1985). Both the prospective Nurses 
Health Study (Manson et al., 1995), which included approximately 115,000 women, 
and a 26-year follow-up of over 5,000 patients in the Framingham Heart Study 
(Hubert et al., 1983) showed an increased risk of mortality as BMI increases. 
Similarly, the American Cancer Society’s Cancer Prevention Study found that a 
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higher BMI is associated 
with greater mortality 
(Stevens et al., 1998). 
Indeed, individuals with a 
BMI of 19 to 24.9 are at a 
20% increased risk of death, 
which increases to 30% for a 
BMI over 25, 60% for a 
BMI over 27, and exceeds 
110% for a BMI over 29 
(Figure 1.1) (Calle et al., 
1999). 
 In addition to 
incurring a higher risk of 
mortality, obese individuals 
are constantly subjected to social pressure as well as societal stigma, and thus face a 
tremendous pyscosocial burden (Friedman, 2003). Obese people often have a poor 
self image and impaired social skills, both of which are exacerbated by societal 
discrimination against the obese (Bennett, 1996; Crocker et al., 1993; Friedman, 
2000). Overweight individuals are more likely to be categorized as having negative 
personality traits and thought of as being unhappy (Hiller, 1981). Furthermore, 
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studies have demonstrated that the obese are victims of prejudice and discriminatory 
behavior that negatively affects their education, employment, health care, and 
economic status (Bennett, 1996; Puhl and Brownell, 2001; Sarlio-Lahteenkorva et al., 
1995). As a result of this stigmatization, obese individuals are subject to 
psychological distress, poor self-esteem, and sometimes worsening weight problems 
(Myers and Rosen, 1999). 
Increasing Prevalence of Obesity 
 Obesity is rapidly emerging as a significant global health problem, and has 
joined the ranks of malnutrition and infectious disease as a leading contributor to poor 
health in the world (Kopelman, 2000). The most recent National Health and Nutrition 
Examination Survey (NHANES) indicates that 66% of adults in the US are either 
overweight or obese, a cohort that has been growing over the last fourty years (Ogden 
et al., 2006). Obese individuals made up 32.2% of the US adult population in 2004, as 
compared to 12.8% in 1962 (Kuczmarski et al., 1994). This trend manifests itself in 
younger individuals as well, and has shown an even more alarming rate of increase in 
children and adolescents. As a matter of fact, the prevalence of overweight children in 
the US has more than doubled since 1976 (Troiano et al., 1995; Yanovski and 
Yanovski, 2002). Since the presence of obesity in early infancy, childhood, and 
adolescence markedly increases the risk for obesity in adulthood, these youngsters are 
often predisposed to a lifetime of health problems (Dietz, 1994). 
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Though obesity is often viewed as a problem only encountered in countries of 
affluence, it is actually rapidly increasing in the developing world (Taubes, 1998). In 
fact, it is estimated that the number of obese people in the world is equivalent to those 
suffering from hunger (Campbell, 2000). Obesity has also taken a hold in countries 
such as Japan, Korea, China, and Thailand - nations where it has traditionally not 
been a concern (Popkin, 1994). Similar trends in obesity have been observed 
throughout Europe as well, though they are reported to be less severe (W.H.O., 1988). 
On the other hand, obesity rates amongst Pacific Islanders are astonishingly high, 
with a prevalence of over 60% in certain populations (Hodge et al., 1995; Shmulewitz 
et al., 2001). 
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When discussing trends in the prevalence of obesity, we must keep in mind 
that the disorder is defined as a threshold (i.e. BMI > 30), and thus relatively small 
increases in average weight can have a disproportionate effect on its incidence 
(Friedman, 2003). For example, while the incidence of obesity in the US increased by 
one third from 1991 to 2000 (i.e. 23.3% to 30.9%), the average weight of a typical 
American rose by approximately 7 to 10 pounds (Flegal and Troiano, 2000). 
Therefore, an increase in the average BMI of the US population from 26.7 to 28.1, 
lead to a marked increase in people with a BMI > 30, and hence the sharp rise in 
obese individuals (Figure 1.4) (Friedman, 2003). 
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Nature vs. Nurture, A Closer Look at the Causes of Obesity 
 
Environmental Contributions to Obesity 
 Billions of dollars are generated in revenue every year by the diet industry, 
with over 30% of adults in the United States reporting that they are trying to loose 
weight (Friedman, 2000; Serdula et al., 1999). A fundamental concept presented in 
the marketing of many diets is the idea that adjustments to body weight are simply a 
matter of determination. The common oversimplification that obesity results solely 
from a lack of willpower, gluttony, and utter laziness has in recent years been 
challenged by a wealth of scientific knowledge. Clinical and molecular studies have 
shed light on the interplay between genes and the environment in leading to the 
disorder of energy imbalance, and it has become quite clear that both factors play a 
determining role when it comes to an individual’s body weight. 
 The environment can be looked upon as contributing to the development of 
obesity in whichever ways it increases the frequency of behaviors that promote 
positive energy balance (Hill and Peters, 1998). In today’s society, the availability of 
food, popularity of high calorie meals and drinks, and increased portion size, have all 
contributed to the increased prevalence of obesity. Even with the call to alarm against 
trends in weight gain, foods low in fats or carbohydrates, but high in calories, have 
been marketed as smart and guilt-free alternatives. 
 Alongside this increase in caloric intake over recent history, modernization 
has brought with it a decrease in physical activity. Studies have shown that children 
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spend an increased amount of leisure time watching television or playing video 
games, which may be contributing to the observed increase in childhood obesity 
(Robinson, 2001). This makes sense, as reduced physical activity and low energy 
expenditure are risk factors for weight gain (Ravussin et al., 1988a; Rissanen et al., 
1991). 
 Since the human genome has not changed significantly in the last 20 years 
(Hill and Peters, 1998), much of the blame for the increase in obesity can be placed 
on environmental factors. This hypothesis is reinforced by studies of migrant 
populations, one of which shows that the likelihood of an Asian American individual 
being overweight or obese increases with the number of years he/she has spent in the 
US (Lauderdale and Rathouz, 2000). Another such study shows that obesity is more 
prevalent amongst American-born versus foreign-born individuals, and increases 
greatly in second and third generation immigrants (Popkin and Udry, 1998). 
The Genetic Influence Over Obesity 
In addition to the environmental contributions to body weight, there is a 
precise physiological mechanism rooted in genetics that exerts control over energy 
balance. Obesity genes code for the molecular components that regulate the 
homeostasis between energetic inputs and outputs, a system that precisely matches 
caloric consumption with caloric expenditure to maintain controlled stores of energy, 
mainly in the form of fat (Spiegelman and Flier, 2001; Zhang et al., 1994). 
Exemplifying this is the fact that a typical human being consumes approximately 10 
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million calories over the course of a decade, with generally only a modest change in 
body weight (Friedman, 2003). Calculations show that this trend requires food intake 
and energy expenditure to match one another within 0.17% (Weigle, 1994), a level of 
precision that exceeds the ability of nutritionists to count calories by several orders of 
magnitude. The ‘set point’ hypothesis buds from this inherent stability in body 
weight, and proposes that food intake and energy expenditure are coordinated to keep 
body weight relatively constant (Friedman and Leibel, 1992; Harris, 1990). In support 
of this theory, when a study restricted food intake to reduce body weight by 10%, it 
found that energy expenditure decreased to offset the attempted changes (Leibel et al., 
1995). 
 If such a precise homeostatic mechanism for the regulation of body weight 
exists, then why has average body weight, and thus obesity, climbed so drastically 
over the last few decades? Shouldn’t this physiological system resist changes in 
weight due to the abundance of calories or sedentary lifestyle that has become so 
pervasive in modern day society? To answer these questions, we can turn to the 
“thrifty gene hypothesis”. This theory says that genes which allowed for the effective 
storage of energy as adipose tissue when food was scarce, as was the case in ancient 
hunter-gatherer societies, provided an adaptive advantage and were selected for over 
time (Neel, 1999). Thus, individuals that were able to store energy to use during times 
of food deprivation were able to survive longer and pass on the genes that allowed 
them to do so to a larger fraction of the next generation. The relatively sudden change 
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in environment that has made access to calorie dense food commonplace, has in the 
context of thousands of years of selection for “thrifty genes” made obesity a serious 
health problem. 
 If the change in environment has provided the bricks with which the house of 
obesity has been built, then genetic factors are the foundation holding it up. As much 
as 80% of the variance seen in BMI amongst individuals is attributable to differences 
in genetic makeup (Rosenbaum et al., 1997). An individual’s genes govern his/her 
control over positive energy balance and defense system against developing obesity 
in a particular environment (Hill and Peters, 1998). Studies of adopted children, twins 
reared together or apart, and patterns of familial aggregation have all supported the 
importance of genetic factors in the determination of BMI. A study of over 100,000 
people from either biological or adoptive relationships found a BMI correlation of 
0.70 in monozygotic twins and 0.32 in dizygotic twins, which represents a heritability 
of 50-90% (Maes et al., 1997). This high heritability is equivalent to that of height 
and far exceeds that of many disorders generally considered to have a genetic basis 
(Allison et al., 1996). 
Additional studies show that identical twins that have been reared apart have 
only a slightly lower correlation in BMI than those that have been raised together, and 
a shared childhood environment does not affect the similarity of their BMI later in life 
(Stunkard et al., 1990). On the flip side of the coin, adoptees raised together do not 
exhibit any correlation between BMIs (Stunkard et al., 1986). Furthermore, the rate 
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and proportion of weight gain, as well as the site of fat deposition, are all more 
closely linked in within pairs of identical twins than between them (Bouchard et al., 
1990). This effect is also seen in mice, where genetically distinct inbred strains show 
very different amounts of weight gain in response to a high fat diet (West et al., 1992; 
West et al., 1994). A hypothesis that accounts for both the genetic foundation of 
obesity as well as the environmental contribution to it, proposes that susceptibility to 
obesity is under genetic control and that behavior and environment determine the 
phenotypic expression of inherited susceptibility genes (Barsh et al., 2000). 
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Body Energy Homeostasis 
 
The Balance Between Energy Intake and Expenditure 
 Obesity, defined medically as a state of increased body weight to the extent 
that produces adverse health consequences, is a disease of energy imbalance. When 
energy intake exceeds energy expenditure, the excess calories are stored as fat. If this 
state of positive energy balance continues over time, so will weight gain that 
eventually leads to obesity. Assuming that an individual has no problems with the 
absorption of nutrients, energy intake will be directly proportional to the calories that 
he/she consumes. 
 Energy expenditure, on 
the other hand, is a bit more 
complex, and represents the 
conversion of oxygen and an 
energy source (fats, 
carbohydrates, and proteins) to 
carbon dioxide, water, heat 
and work on the environment 
(Lowell and Spiegelman, 
2000). It takes the form of 
physical activity, basal 
metabolism, and adaptive 
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thermogenesis – which refers to energy dissipated in the form of heat in response to a 
change in the environment, such as cold exposure or diet alterations (Figure 1.3) 
(Lowell and Spiegelman, 2000). Basal metabolic rate (BMR) refers to the numerous 
biochemical processes required to sustain life, and is traditionally defined as the 
minimal caloric requirement for an organism to maintain life in the absence of 
external stimulation, work and growth (Harper et al., 2001a). There are many 
physiological processes that continue in an organism at this state, including blood 
circulation and respiration. The reactions that contribute to BMR on a cellular level 
include protein turnover, ion cycling across the plasma membrane, turnover of 
nucleic acids and lipids, and proton flux across the mitochondrial inner membrane 
(Brand, 1990; Hulbert and Else, 2000). 
 It is important to realize that a process can only cause or prevent obesity if it 
affects the overall energy equation of an organism (Spiegelman and Flier, 2001). An 
example of deviation from this understanding is the thought that limiting adipose 
tissue development can rectify obesity and its complications. However, experiments 
in which fat cell differentiation, development, and survival have been diminished 
show that this is not the case. Instead of producing healthy and obesity resistant 
organisms, these studies created mice that suffered from the lack of an appropriate 
depot in which to deposit excess energy, and exhibited a loss of critical adipocyte 
derived hormones (Ross et al., 1993; Shimomura et al., 1998). As a result, these mice 
had increased levels of blood lipids, fatty livers and diabetes, the combination of 
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which lead to death. Along these lines, when a genetically altered mouse is found to 
be leaner, one can conclude that an alteration has taken place in the total energy 
balance scheme – usually involving food intake or energy expenditure (Spiegelman 
and Flier, 2001). 
Central Regulation of Energy Balance 
 The central nervous system (CNS) regulates energy balance, and thus body 
weight, through its effects on behavior (i.e. feeding and physical activity), the 
autonomic nervous system (regulation of energy expenditure and other aspects of 
metabolism), and the neuroendocrine system (i.e. growth hormone, thyroid hormone, 
cortisol, insulin, and sex steroids). The effectiveness of this system is highlighted by 
data showing that many species forced to gain weight by overfeeding, or lose weight 
by food restriction, will return to their control body weight levels upon return to 
voluntary food intake (Harris, 1990; Kandel et al., 2000).  
 The location of such a CNS energy regulation system was implicated through 
observations that animals with lesions in the hypothalamus demonstrated 
dysregulation of body weight and had excess fat mass (Harris, 1990; Hetherington 
and Ranson, 1942). Further studies showed that different regions of the hypothalamus 
have distinct contributions to energy regulation. Lesions of the lateral hypothalamus 
result in increased energy expenditure and decreased food intake, which work in 
concert to decrease body fat mass. Conversely, lesions in the ventromedial 
hypothalamus result in hyperphagia and obesity (Hetherington and Ranson, 1942; 
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Powley and Keesey, 1970). Thus, through these experiments it was hypothesized that 
the lateral hypothalamus was the feeding center of the brain, while the ventromedial 
hypothalamus was the satiety center. The identification of leptin as the signal which 
indicated lipid energy stores to these centers was crucial in uncovering how they 
maintain body weight homeostasis, and is discussed in the next section.  
Short and Long Term Regulation of Energy Intake 
 The decision to begin and end feeding involves the integration of a number of 
factors, including food availability, metabolic status, hormone levels, and neural 
signaling – including visual, olfactory, emotional, and cognitive inputs (Schwartz et 
al., 2000b). The factors regulating food intake can be divided between short-term 
signals, which involve the initiation and termination of meals, and long-term signals, 
which promote regulation of caloric stores and energy homeostasis. Induction of 
satiety is the major determinant of meal size, and is the result of neural and endocrine 
inputs, such as gut distention and the release of cholecystokinin (CCK) (Moran, 
2000). Regulation at the level of individual meal size is insufficient to account for 
energy homeostasis over longer periods of time, as mice repeatedly injected with 
CCK retain weight by ingesting a larger number of small meals (Spiegelman and 
Flier, 2001). Therefore, long-term signals that reflect the status of energy stores, such 
as the fat derived hormone leptin, are required to maintain energy balance. 
16
Discovery of Leptin and its Receptor 
 
A Circulating Signal of Energy Stores 
 Support for a circulating factor in the blood as the afferent signal of energy 
stores was popularized by the observation that transferring the blood of an obese 
animal with a lesion in the ventromedial hypothalamus into a lean animal caused the 
later to decrease food intake and lose body fat (Hervey, 1959). Kennedy had also 
proposed a “lipostatic theory”, in which the hypothalamus responded to an adipose 
secreted “satiety factor” that circulated in the blood. He postulated that such a factor 
should have three defining 
characteristics: it should be 
produced by adipose tissue, it 
should circulate in the plasma, 
and it should be proportional to 
fat mass (Kennedy, 1953). 
Further support for such 
a circulating signal of satiety 
came from Coleman’s parabiosis 
experiments, in which the 
circulations of two mice were 
fused. In these studies, when a 
wild-type and ob/ob mouse were 
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fused, the ob/ob mouse decreased its food intake and lost weight, indicating that there 
is a circulating factor that the ob/ob mouse lacks (Figure 1.4, bottom panel). This 
factor is also present in the db/db mouse, which when fused with an ob/ob can make 
it loose weight as well (Figure 1.4, middle panel). The fusion of a db/db mouse with a 
wild-type mouse resulted in death of the wild-type mouse by self imposed starvation 
and no significant changes in the db/db animal, suggesting that the obesity seen in 
db/db mice may be the result of resistance to this factor (Figure 1.4, top panel). 
Positional Cloning of the ob Gene, and Identification of Leptin 
Kennedy’s proposed “satiety factor” was discovered with the positional 
cloning of the ob gene, which was found to have high expressivity in adipose tissue 
(Zhang et al., 1994). The protein product of this gene was named leptin, from the 
Greek word leptos, meaning thin. Leptin fulfils all the requirements set by Kennedy 
for his factor: it is produced primarily by adipose tissue in nonpregnant animals 
(Zhang et al., 1994), it is a 16 kilodalton circulating member of the long-chain helical 
cytokine family (Zhang et al., 1997), and it is highly correlated with BMI in humans 
(Maffei et al., 1995). 
Leptin conveys satiety by functioning as the afferent signal in a negative 
feedback loop regulating adipose tissue mass. When one is at his/her stable weight, 
the amount of leptin in circulation maintains body energy homeostasis by eliciting a 
state where food intake equals energy expenditure (Figure 1.5, top panel) (Friedman, 
2000). A decrease in fat reserves reduces the amount of circulating leptin, which 
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signals to the 
hypothalamus to increase 
food intake and decrease 
energy expenditure 
(Figure 1.5, second 
panel). Conversely, 
increased fat reserves 
raise circulating levels of 
leptin, which triggers the 
hypothalamus to cut 
back food intake and increase energy expenditure (Figure 1.5, third panel). In most 
obese individuals there is a decreased sensitivity to leptin, and thus even at higher 
circulating levels of the hormone, they maintain body energy homeostasis by 
balancing food intake with energy expenditure (Figure 1.5, bottom panel). 
Mouse Models to Study the Function of Leptin 
The ob knockout mouse model that lead to the identification of leptin can also 
be used to study the hormone. There are two such mutant strains of mice that are 
unable to produce leptin. The more commonly used ob1j mutant has a nonsense 
mutation in the leptin gene, which results in a truncated protein that is not secreted 
into circulation (Zhang et al., 1994). The levels of ob RNA are elevated in the 
adipocytes of this mutant, suggesting that leptin expression may be under feedback 
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regulation. In the ob2j mutant, on the other hand, the first intron of the gene has an Etn 
transposon inserted into it. This generates hybrid RNAs where the splice donor of the 
non-coding first exon is joined with the splice acceptor of the transposon, which 
prevents the formation of mature RNA (Moon and Friedman, 1997). 
The defect in the production of leptin in these ob mice leads to animals that 
are hyperphagic and hypometabolic, rendering them obese from a very young age. In 
addition to being obese, ob/ob animals are diabetic, hypothermic, sterile, and show 
decreased immune function (Coleman, 1978). These mice behave very much like 
animals that have been starved, since in the absence of leptin their bodies are under 
the perception of being in extreme negative energy balance. Thus the functions less 
critical for short-term survival in a nutritionally deficient state, such as reproductive 
capability, are forgone to conserve as much energy as possible. 
Restoration of physiological levels of leptin by intraperitoneal injection or 
subcutaneous infusion of the hormone in ob/ob mice leads to a dose-dependent 
decrease in body weight and food intake, corrects the metabolic defects discussed 
above, and restores fertility (Campfield et al., 1995; Halaas et al., 1995; 
Pelleymounter et al., 1995). Furthermore, leptin treatment of these mice improves 
their hyperglycemia, hyperinsulinemia, and hypercorticosteronemia (Pelleymounter et 
al., 1995; Stephens et al., 1995). It is interesting to note that the reduction in body 
weight resulting from leptin treatment is specifically due to the depletion of adipose 
tissue and does not involve any changes in lean body mass (Halaas et al., 1995). In 
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support of this observation, adenovirus-mediated leptin gene therapy specifically 
depletes fat mass as well (Chen et al., 1996a). 
The Leptin Receptor 
Another monogenic mutation inherited in an autosomal recessive fashion, 
which also left animals obese and diabetic, was described alongside ob (Coleman, 
1978). Mice with this mutation were called db, for diabetic, and the protein product of 
this gene was later shown to code for the leptin receptor Ob-R (Chen et al., 1996b; 
Tartaglia et al., 1995). Ob-R is a receptor that spans the plasma membrane, and has 
five alternatively spliced variants (Chen et al., 1996b; Chua et al., 1996; Lee et al., 
1996). The C57Bl/Ks strain of db mice has an insert that leads to an alternatively 
spliced transcript containing a premature stop codon, which inhibits the expression of 
Ob-Rb. Other isoforms of the Ob receptor, however, are not affected by this mutation 
and remain intact (Chen et al., 1996b; Lee et al., 1996). The fact that C57Bl/Ks mice 
exhibit the same phenotype as animals unable to make any of the Ob-R isoforms 
suggests that Ob-Rb is the receptor splice variant that is critical in detecting leptin 
levels. In other studies, leptin had no effect on STAT or JAK activation in cells that 
only expressed Ob-Ra, providing further support for the importance of Ob-Rb 
(Ghilardi and Skoda, 1997; Ghilardi et al., 1996). 
 This long form of the ob receptor, Ob-Rb, is the only splice variant with an 
intracellular domain capable of transducing signals. When leptin binds to this 
receptor, the later is phosphorylated on at least two intracellular tyrosine residues, 
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namely Tyr985 and Tyr1138 (Li and Friedman, 1999). The phosphorylation of 
Tyr1138 is followed by the phosphorylation of JAK-2 and STAT-3, which leads to 
suppressor of cytokine signaling (SOCS)-3 transcription (Banks et al., 2000). Along 
these lines, cells transfected with the mutant receptor found in db/db mice showed 
defective STAT signaling (Ghilardi et al., 1996). Furthermore, leptin injection leads 
to a dose-dependent activation of STAT-3 in the hypothalamus of wild-type and 
ob/ob mice, but not db/db mice (Vaisse et al., 1996). Finally, leptin induces the 
expression of the STAT-3 target gene fos in the hypothalamus (Woods and Stock, 
1996). 
Once SOCS-3 transcription has been activated, Tyr985 comes into play, as it 
is needed in the negative regulation of the leptin receptor by SOCS-3 (Bjorbak et al., 
2000). Peripheral administration of leptin has been shown to up-regulate 
hypothalamic levels of SOCS-3 mRNA (Bjorbaek et al., 1998). SOCS proteins 
negatively feedback on receptor signaling in response to cytokine stimulation, and 
levels of SOCS-3 remain up regulated for 20 hours after leptin administration, 
indicating long-term effects. Furthermore, SOCS-3 is over expressed in the 
hypothalamus of Ay obese mice, and its over expression in cell culture leads to 
inhibition of Ob-Rb signaling. These observations suggest that SOCS-3 may be 
involved in leptin’s role in resisting obesity (Bjorbaek et al., 1999; Bjorbaek et al., 
1998). 
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In addition to playing a role in the negative regulation of the leptin receptor, 
Tyr985 leads to docking and phosphorylation of the SH2 domain containing protein 
tyrosine phosphatase (SHP)-2 (Carpenter et al., 1998; Li and Friedman, 1999). SHP-2 
decreases Jak2 phosphorylation, and thus blunts leptin signal transduction (Carpenter 
et al., 1998; Li and Friedman, 1999). Protein-tyrosine phosphatase, PTP1B, also 
decreases Jak2 phosphorylation, and thus mice lacking the former have increased 
levels of phosphorylated STAT-3, and are resistant to obesity (Cheng et al., 2002; 
Cook and Unger, 2002; Elchebly et al., 1999; Zabolothy et al., 2002). The full 
significance of these signaling cascades remains to be demonstrated in vivo, and a 
deeper understanding of them may be valuable in comprehending physiological 
disturbances resulting in obesity. 
Ob-Rb has been detected in T cells, lymph nodes, the jejunum and vascular 
endothelium, however its highest expression seems to be in hypothalamic neurons 
(Chen et al., 1996b; Ghilardi et al., 1996; Lord, 1998; Morton et al., 1998). In situ 
hybridization studies have shown the receptor to be located in the arcuate nucleus, 
paraventricular nucleus (PVN), dorsomedial hypothalamic nucleus (DMH), 
ventromedial hypothalamic nucleus (VMH), and lateral hypothalamus (LH) – brain 
regions known to be involved in regulating appetite and body weight (Elmquist et al., 
1997; Elmquist et al., 1998; Fei et al., 1997; Hetherington and Ranson, 1942; Mercer 
et al., 1996). 
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 Currently, a definitive role for the other isoforms of Ob-R remains to be 
established. Ob-Ra and Ob-Rc are expressed on the microvasculature of the brain, 
and it has been suggested that they may be involved in leptin transport across the 
blood brain barrier (Banks et al., 1996; Hileman et al., 2002). Another splice variant, 
Ob-Re, is a soluble isform of the receptor, which appears to bind leptin in the plasma 
and assist in its action (Huang et al., 2001; Li et al., 1998). 
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Leptin’s Role in Body Weight Regulation 
 
Central vs. Peripheral Mechanisms of Action 
 The hypothalamus is the master regulator of energy balance in the brain, and 
is a major center of integration for leptin signaling. Ob-Rb is highly expressed in the 
hypothalamus and rats with lesions in this brain region exhibit leptin resistance, 
indicating that leptin has direct effects on the brain (Satoh et al., 1997). Intra-cerebro-
ventricular (I.C.V) injection of leptin reduces food intake, increases energy 
expenditure, and results in weight loss (Campfield et al., 1995). Furthermore, leptin 
administered at extremely low doses by this means elicits the same weight loss and 
anorectic effects as much higher doses given peripherally (Halaas et al., 1997; 
Stephens et al., 1995). Administered peripherally, a leptin dose of 200ng/hr in ob/ob 
mice and 500ng/hr in wt mice is required for complete depletion of adipose tissue, 
and even higher levels are required when the hormone is given as twice daily 
injections (Halaas et al., 1995). On the contrary, chronic I.C.V. injection of just 3 
ng/hr produces the same effects without increasing circulating leptin levels (Halaas et 
al., 1997). Furthermore, leptin rapidly induces STAT-3 DNA binding in the 
hypothalamus in a dose dependant manner, an effect that is not seen in any other 
tested tissues (Vaisse et al., 1996). Leptin administered either peripherally or centrally 
does not induce STAT-3 or cause weight loss in db/db mice (Halaas et al., 1995; 
Vaisse et al., 1996). Finally, brain specific expression of leptin receptors in receptor 
deficient mice can reverse many aspects of leptin deficiency (Kowalski et al., 2001). 
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As a whole, these data strongly suggest that leptin’s actions are mediated in a large 
part through the hypothalamus. 
 It is important to keep in mind, however, that the leptin receptor is broadly 
expressed and leptin does have some direct effects on peripheral tissues. For example, 
leptin can influence the immune system, angiogenesis, and bone metabolism (Ducy et 
al., 2000; Lord, 1998; Sierra-Honigmann et al., 1998). More specifically, leptin has 
been reported to have effects on immune cells, muscle, liver, fat, heart, pancreatic β-
cells, and other cell types (Kim et al., 2000; Lord, 1998; Minokoshi et al., 2002; 
O'Rourke et al., 2001; Shimabukuro et al., 1997). Interestingly, both neural pathways 
and direct actions in the periphery mediate leptin’s activation of AMP kinase in 
peripheral tissues, which plays a role in regulating the oxidation of lipids (Minokoshi 
et al., 2002). That being said, the weight reducing effects of leptin which are the main 
focus of this thesis, are in large part mediated by the hypothalamus as discussed 
above. 
The Leptin Regulated Melanocortin Pathway 
Targeted deletions and positional cloning of genes, functional neuroanatomy, 
and identification of mutant genes in human obesity have all made it possible to gain 
insight into the complex central circuits that regulate energy balance. Though there 
are a number of brain centers that express leptin receptors and respond to the 
hormone, the best characterized and most clinically relevant of these help comprise 
the leptin-regulated melanocortin circuit. Seven unique proteins have been shown to 
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contribute to weight regulation and obesity in the major components of this circuit, 
which are detailed in Figure 1.6 (Spiegelman and Flier, 2001). In this circuit, leptin 
acts on two distinct populations of neurons in the arcuate nucleus, namely 
NPY/AgRP cells and POMC/CART cells. NPY and AgRP are orexigenic 
neuropeptides, and leptin action reduces their expression (Elias et al., 1999; Elmquist 
et al., 1999b; Schwartz et al., 2000b). POMC and CART, on the other hand, are 
anorexigenic neuropeptides, and leptin action induces their expression (Elias et al., 
1999; Elmquist et al., 1999b; Schwartz et al., 2000b). Therefore, leptin signaling in 
the arcuate nucleus through Ob-Rb receptors suppresses two orexigenic peptides and 
induces two anorexigenic peptides. 
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These neuropeptides then go on to influence second order targets in the 
hypothalamus. POMC neurons produce αMSH, which stimulates MC4R receptors 
found in the brain and reduces food intake. On the other hand, AgRP works to inhibit 
MC4R receptors, which increases feeding and diminishes the hypophagic response to 
leptin (Cone, 1999; Fan et al., 1997). Transgenic and pharmacologic experiments 
have shown that the dominant obesity syndrome exhibited by the Ay mouse is due to 
ectopic expression of the agouti protein that produces obesity by antagonizing the 
action of αMSH on MCR4 receptors in the brain (Fan et al., 1997; Graham et al., 
1997; Lu et al., 1994; Ollmann et al., 1997). The action of agouti in these mice 
mimics that of AgRP, which is its hypothalamic homolog. 
Mice with one copy of the MC4R gene knocked out display moderate obesity, 
and those with a homozygous deletion of the receptor are fully obese (Huszar et al., 
1997). In humans, approximate 4-5% of severe obesity is due to mutation at this 
location. The disorder in these individuals seems to arise due to haploinsufficiency 
rather than a dominant negative mechanism (Farooqi et al., 2000). These findings 
highlight the importance of the melanocortin pathway in maintaining normal energy 
balance, and suggest that it is extremely tightly regulated (Spiegelman and Flier, 
2001). 
The melanocortin pathway is also involved in a number of other human and 
murine causes of obesity. One such example, which leads to obesity in both 
organisms, occurs due to a mutation in the POMC gene that prevents the synthesis of 
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αMSH (Krude et al., 1998). Other such mutations that function through POMC 
processing occur in the enzymes PC-1 and CPE, and cause obesity in humans and 
mice respectively (Barsh et al., 2000). Obesity in mice also results from the targeted 
deletion of the MC3R gene, which codes for receptors closely related to MC4R 
(Butler et al., 2000). Since the obesity observed with MC3R deletions occurs without 
the hyperphagia seen in deletions of MC4R, it is thought that they are involved in 
distinct physiological pathways. Melanocortin systems, along with serotonin 
pathways, may also be involved in cachexia and eating disorders such as anorexia 
nervosa (Marks et al., 2001). 
Leptin and the Melanin Concentrating Hormone Circuit 
Lesion studies have implicated the lateral hypothalamus and zona incerta as 
“feeding centers” of 
the brain. Melanin 
concentrating 
hormone (MCH), 
another hypothalamic 
peptide involved in 
weight regulation, is 
exclusively 
expressed in large 
neurons whose cell 
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bodies reside in these areas (Flier, 2004a)(Figure 1.7). Research has also confirmed a 
connection between arcuate neurons expressing AGRP/NPY and POMC/CART, and 
neurons in the lateral hypothalamus expressing MCH (Elias et al., 1999). Over-
expression of MCH in the brain results in obesity and increased susceptibility to a 
high fat diet (Ludwig, 2002). Conversely, deletion of the MCH gene produces a 
mouse that is lean as the result of hypophagia and increased energy expenditure 
(Shimada et al., 1998). Knocking out this gene also substantially suppresses many 
aspects of the ob/ob phenotype (Segal-Lieberman et al., 2003). 
The MCH receptor, MCHR1, is a G protein coupled receptor that is expressed 
widely in the brain. Targeted deletion of this receptor produces a mouse that is lean 
due to increased energy expenditure rather than reduced caloric intake (Marsh et al., 
2002). Antagonists to the MCHR1 receptor suppress food intake and resist the obesity 
that develops in mice fed a palatable diet (Borowsky et al., 2002). 
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Obesity, Energy Expenditure, and the Role of Leptin 
 
Energy Expenditure is Defective in Obesity 
 There are many lines of support for defects in energy expenditure underlying 
obesity, the strongest of which come from monogenic rodent models such as ob/ob, 
db/db, and melanocortin-4 receptor gene knock out mice (Lowell and Bachman, 
2003). In all three of these genetic models, when food intake is restricted to that of 
wild-type controls, marked obesity still develops (Coleman, 1978). Furthermore, 
animals in which hypothalamic lesions are induced also become obese when food 
restricted to sham-treated control levels (Bray and York, 1979). Indeed, there are a 
few exceptions to the rule that animal models of obesity, whether generated through 
genetic manipulation or induced through lesions, have decreased energy expenditure 
(Lowell and Bachman, 2003). Studies also suggest that obesity in humans is caused at 
least in part by reduced energy expenditure. For example, low energy expenditure, 
normalized for lean body mass, has been shown to be predictive of future weight gain 
(Ravussin et al., 1988a). Thus comprehending the role of energy expenditure in 
obesity is critical to understanding the disorder and devising therapies to combat it. 
Standard Metabolic Rate 
 As discussed earlier, basal metabolic rate (BMR) represents the minimal 
calories required for an organism to maintain the basic functions of life in the absence 
of external stimulation, work and growth. BMR and resting metabolic rate (RMR) are 
difficult and not suitable to measure in animals, and thus standard metabolic rate 
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(SMR) is used instead (Harper et al., 2001b). SMR is defined as the amount energy 
expenditure for an adult organism that is awake but resting, not digesting food, and is 
at thermoneutrality – the environmental temperature at which no energy has to be 
expended to maintain body temperature (Lowell and Spiegelman, 2000). There is a 
large spectrum of varying SMRs across phyla, and endotherms have a five fold 
greater metabolic rate than ectotherms of the same size (Rolfe and Brown, 1997). 
Furthermore, SMR within a phylum is inversely correlated with body size (Porter and 
Brand, 1993). The differences in SMR that exist amongst phyla and species suggest 
the presence of regulatory mechanisms that may be manipulated pharmacologically to 
change energy balance and increase adaptive thermogenesis (Harper et al., 2001b). 
Factors Affecting Adaptive Thermogenesis 
Standard metabolic rate and other such measurements represent the 
conversion of an energy source (food or stored) and oxygen to carbon dioxide, water, 
heat and work on the environment. The presence of heat in the equation above 
highlights the fact that many reactions in energy metabolism, such as those that 
consume ATP or are catalyzed by the mitochondrial respiratory chain, are exothermic 
in nature. Adaptive thermogenesis is defined as heat production in response to 
environmental temperature or diet (Lowell and Spiegelman, 2000). This component 
of energy expenditure serves to protect an organism from cold exposure or changes in 
energy homeostasis after modifications in diet.  
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 The environmental temperature can greatly influence energy expenditure in an 
organism, as highlighted by the fact that oxygen consumption increases by 
approximately 2-4 fold in rodents after both acute and chronic incubation at 4oC 
(Davis et al., 1960; Depocas et al., 1956). Shivering plays a role in maintaining body 
heat in the initial response to this temperature, however with adaptation it disappears 
and other mechanisms, including adaptive thermogenesis, take over (Davis et al., 
1960; Foster and Frydman, 1979). Though the effect seen in humans is smaller, 
changes in environmental temperature show a similar influence over adaptive 
thermogenesis. For example in identically clothed humans, a reduction in ambient 
temperature from 28oC to 22oC causes a 7% increase in heat production (Dauncey, 
1981). 
 Food intake also wields influence over adaptive thermogenesis. For example, 
starvation can decrease resting metabolic rate by up to 40% (Blaxter, 1989). Along 
these lines, adhering to a diet that is able to maintain a 10% reduction in body weight 
is associated with decreased energy expenditure (Leibel et al., 1995). The value of 
such a regulatory mechanism is clear for times in which the availability of caloric 
sources may be scarce, however it serves to counter voluntary weight loss as a result 
of dieting. In the face of this reduced energy expenditure, one must maintain a 
disproportionately low caloric intake to maintain weight loss – a feat that makes 
successful dieting incredibly difficult and leads to the failure of most diets over time 
(Friedman, 2003). 
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 Feeding has the opposite effect on adaptive thermogenesis, and in both 
rodents and humans can increase energy expenditure acutely and in the long term. 
Acutely, feeding can raise metabolic rate by 25-40%, which is referred to as the 
thermic effect of food (Shibata and Bukowiecki, 1987; Sims and Danforth, 1987). 
Increased caloric intake over a prolonged period of time can also increase energy 
expenditure, which protects against the development of obesity (Levine et al., 1999). 
Interestingly, this adaptive response to overfeeding is influenced by genetics 
(Bouchard et al., 1990), and varying genetic backgrounds could leave individuals 
differently prone to developing obesity. 
Central Control of Adaptive Thermogenesis and the Role of Leptin 
As was mentioned earlier in our discussion of the hypothalamic influence over 
energy homoeostasis, destruction of neurons in the hypothalamus results in obesity 
(Elmquist et al., 1999b). The obesity in these cases is usually associated with 
increased caloric intake, however even if food is restricted to the level of control 
animals, obesity still develops (Himms-Hagen, 1989). Furthermore, mutations in 
leptin and its receptor, MCR4, and MCH all influence both food intake and energy 
expenditure in a concerted way to influence fat storage (Spiegelman and Flier, 2001). 
These findings, along with others, suggest that the hypothalamus has the capacity to 
control adaptive thermogenesis (Lowell and Spiegelman, 2000). 
There are several lines of evidence suggesting that the sympathetic nervous 
system is the main efferent pathway through which the hypothalamus exerts its 
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control over adaptive thermogenesis (Lowell and Bachman, 2003). First of all, cold 
exposure and diet increase sympathetic nerve activity (Landsberg et al., 1984). 
Secondly, exogenous administration of epinephrine and norepinephrine, both in vivo 
and in vitro, stimulates energy expenditure. Thirdly, brown adipose tissue is highly 
innervated by sympathetic nerves, and the thermogenic activity of it is completely 
dependent on intact sympathetic stimulation (Himms-Hagen, 1989). Our current 
understanding of diet-induced thermogenesis is summarized in figure 1.8 (Lowell and 
Bachman, 2003). As shown in the figure, diet and leptin act on the hypothalamus and 
regulate sympathetic nerve activity to increase energy expenditure in different tissues. 
While much focus has been directed on the importance of leptin’s role in the 
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control of food intake, it is increasingly clear that differences in energy expenditure, 
basal metabolic rates and/or adaptive thermogenesis, are also important variables that 
contribute to human obesity (Bouchard et al., 1990; Levine et al., 1999; Ravussin, 
1995). This is because in addition to reducing caloric intake, leptin infusion of ob/ob 
mice increases total energy expenditure, selectively promotes fat metabolism, and 
prevents the fall in adaptive thermogenesis that normally occurs with reduced caloric 
intake (Doring et al., 1998; Halaas et al., 1997; Hwa et al., 1997; Kamohara et al., 
1997; Mistry et al., 1997; Pelleymounter et al., 1995; Scarpace et al., 1997; van Dijk 
et al., 1999). By adjusting for changes in physical activity, it has been shown that 
leptin infusion doubles the amount of feeding related adaptive thermogenesis by 
acting on both the amplitude and duration of it, and decreases postprandial RQ 
(Ruffin and Nicolaidis, 2000). This conclusion is consistent with the finding that 
stimulation of the ventromedial hypothalamus (VMH), a brain center through which 
leptin exerts some of its catabolic effects as discussed earlier, increases metabolism 
and decreases RQ (Ruffin and Nicolaidis, 1999), while lesions in this area cause 
obesity (Elmquist et al., 1999b). Therefore, a significant portion of leptin-mediated 
weight loss can be attributed to an increase in energy expenditure, including adaptive 
thermogenesis, through the pathway outlined in figure 1.8. 
Target Tissues Mediating Leptin Driven Adaptive Thermogenesis 
While the activation of adaptive thermogenesis in brown adipose tissue by 
sympathetic nerve signaling via β-adrenergic receptors and cyclic AMP is well 
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established, the induction of skeletal muscle and other tissues by this mechanism 
remains to be studied in more detail (Lowell and Spiegelman, 2000). Support for 
similar control over these tissues comes from observations that catecholamine 
infusion into skeletal muscle increases energy expenditure without the performance of 
work (Simonsen et al., 1992). Furthermore, knockout mice unable to produce 
catecholamines show greater sensitivity to cold than do mice mutated in UCP-1 
(Enerback et al., 1997; Thomas and Palmiter, 1997). These studies suggest that 
pathways outside of brown adipose tissue are important contributors to adaptive 
thermogenesis. 
 While leptin’s effects on energy expenditure can be easily demonstrated at the 
level of the whole organism, the tissues responsible for this effect as well as the 
underlying mechanisms are unknown (Lowell and Spiegelman, 2000). Possibilities 
for such tissues include skeletal muscle, liver, white adipose tissue and the heart, and 
are sites of interest as they could be relevant to body weight control in humans 
(Lowell and Bachman, 2003). Several studies have suggested that the liver may 
mediate leptin’s effects on metabolism. This possibility has been suggested based on 
the liver’s integral role in lipid metabolism, its significant energetic demands of 
~20% of standard metabolic rate (SMR) in the rat (Porter and Brand, 1993), and its 
contribution to the catabolic effects of leptin (Cohen et al., 2002). Skeletal muscle and 
the heart are other highly metabolic organs (Rolfe and Brand, 1996; Rolfe et al., 
1999), which have also been suggested to play a role in the increased energy 
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expenditure associated with leptin treatment. However leptin’s effects on metabolism 
or mitochondrial function in these tissues has not been directly studied. 
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 Chapter 2: Materials and Methods 
Leptin Administration 
Male C57BL6/J and C57BL6/J ob/ob mice (8-10 weeks old) were purchased 
from The Jackson Laboratory (Barr Harbor, ME), and housed in individual cages in a 
22oC temperature controlled room, or 30oC incubator (for thermoneutral studies). 
Alzet miniosmotic pumps with a flow rate of 0.5 µl/hr were filled aseptically with 
either sterile PBS or Leptin (400 ng/µl for ob/ob mice ; 1 µg/µl for wt mice ; 5µg/µl 
for wt NC and wt FF mice). The pumps were incubated in a sterile 0.9% NaCl 
solution for at least six hours, and implanted s.c. using isoflurane as an anesthetic. For 
the withdrawal studies, all pumps were surgically removed from treated and control 
animals after eight days, and mice were sacrificed on the fifteenth day (Montez et al., 
2005). For all other studies, mice were sacrificed after twelve days of either saline or 
leptin infusion (Cohen et al., 2002). Pair fed animals were implanted with a PBS 
pump, and fed the same amount of food that their leptin treated counterparts ate on 
the same day. 
Isolation of Mitochondria from Liver 
Mice were sacrificed by cervical dislocation and mitochondrial isolation was 
carried out according to standard procedures (Chappell and Hansford, 1972). Of note, 
it was important not to use CO2 to sacrifice the mice, as doing so may uncouple the 
mitochondria and greatly affect any assays, including differential centrifugation. 
Immediately after sacrifice, livers were excised and rinsed with ice-cold STE buffer 
39
(250mM Sucrose, 5mM Tris, 2mM EGTA, pH to 7.4). In a beaker, the livers were 
chopped with scissors and washed with STE until all the blood was removed. They 
were then homogenized in a glass Dounce homogenizer using 7 strokes of a loose 
pestle, followed by 3 strokes of a tight pestle, in approximately 40ml of STE. The 
homogenate was poured into a falcon tube and centrifuged at 1,047 x g for 3 min at 
4° C. The supernatant was transferred to a new falcon tube and centrifuged at 11,630 
x g for 10 min at 4° C. The supernatant was discarded and the pellets were gently re-
suspended with a re-suspending stick. Care was taken not to disturb any blood spot. 
STE was added to the re-suspended pellets, and the suspension was transferred to a 
clean falcon tube and spun for 10 mins at 11,630 x g. The previous three steps of 
discarding the supernatant, re-suspension and centrifugation, were carried out once 
more. Finally, the mitochondrial extract was re-suspend in approx 200ul of STE. 
Purification of Liver Mitochondria 
In the case of liver mitochondria being used for iTRAQ protein analysis, 
further purification was done using a 5% to 35% continuous gradient of nycodenz 
(Sigma D2158) made in Solution B (0.22M Mannitol, 70mM Sucrose, 1mM EDTA, 
10mM MES, pH 7.5). Mitochondria isolated by the method described above were re-
suspended in Solution B instead of STE in the last step, and loaded onto a continuous 
nycodenz gradient [made by mixing 5% and 35% nycodenz in Solution B using a 
gradient maker]. The tubes were then centrifuged at 75,000 x g in a Beckman SW41 
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Ti swinging-bucket rotor for 2 hours at 4° C). The mitochondrial band was removed 
and assayed for protein content using a 2-D Quant Kit (Amersham Biosciences, NJ). 
Western Blotting to Assess Mitochondrial Purity 
A 12% SDS gel was prepared as follows (recipe for 2 gels): (a) Separation gel 
– 2.5ml 40% Acrylamide (29:1), 2.5 ml 4x Buffer, 4ml H20/Glycerol (10:8), 37.5ul 
10% APS (fresh or frozen), 7.5ul Temed (b) Stacking gel – 0.65ml 40% Acrylamide 
(29:1), 1.25ml 4x Buffer, 3.05ml H20, 25ul 10% APS (fresh or frozen), 5ul Temed. 
The separation gel was poured into the chamber first, adding the stacking gel and 
comb afterwards, and was allowed to sit for 15 mins to polymerize. Next, the 
chamber was filled with running buffer. The gel was run at 70V until the samples 
made it through the stacking gel and were in one straight line, after which the voltage 
was increased to 140V. The gel was run at this voltage for approximately 1.5 hours 
(depending on the percentage of gel). 
The sandwich for blotting was prepared by putting the following on the white 
side (positive side) of the sandwich maker: a) pad soaked in running buffer, b) 
whatman paper, c) membrane, d) gel, e) whatman paper, f) pad soaked in running 
buffer. The chamber was filled with blotting buffer and run in the cold room for three 
hours at 38V. An ice holder and a stir bar were placed in the chamber to keep the 
temperature down. After it had been run, the membrane was blocked for 30-60 mins 
with 0.75g of fat-free powdered milk in 15ml of TBS-T. It was then washed with 
TBS-T three times for 5 minutes each cycle. 
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The 1° antibody was made by adding 0.75g of fat-free powdered milk to 15ml 
of TBS-T and the appropriate amount of 1° antibody. The membrane was incubated 
with this mixture overnight at 4°C. The next morning, the membrane was washed 
with TBS-T three times for at least 8 minutes each cycle. The 2° antibody was then 
made by adding 0.75g fat-free powdered milk to 15ml of TBS-T and the appropriate 
amount of antibody. The membrane was incubated with this mixture for 30min at 
room temperature. After the incubation, the membrane was washed with TBS-T four 
times for 15 mins each cycle. Finally, the membrane was dried shortly by waving it in 
the air. 
Equal volumes of detection reagent 1 and detection reagent 2 (for a total 
volume of 750ul for each membrane) were added to the membrane, and it was 
covered with saran wrap. In wrapping the membrane care was taken to make sure 
there were no air bubbles. The membrane was incubated in this mixture for one 
minute, removed, and dried shortly by waving in the air. Next, the membrane was 
covered in saran wrap and taped to the top left corner of an exposure cassette. The 
film put in the cassette was exposed to the film for 30sec, 1min, 2min, and 5min on 
each of the four corners. Finally, the film was put in the developer. 
Isolation of Mitochondria from Skeletal Muscle 
Mice were sacrificed by cervical dislocation and as much tissue as possible 
was harvested from the hamstrings, calf, quadriceps, triceps, and pectoral muscles. As 
it was being collected, the skeletal muscle tissue was placed in CPI medium (0.1M 
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KCl, 0.05M Tris-HCl, 2mM EGTA, pH 7.4) on ice. At the end of the collection, the 
medium was poured away, the tissue was weighed (should have approx 11-12g tissue 
/ 5 mice), and more CP1 medium was immediately added to the tissue. A small 
amount of tissue was taken and cut with sharp scissors to the smallest pieces possible. 
This was repeated until all the tissue has been minced in this way.  
The tissue was then chopped further with scissors in a beaker. The muscle was 
allowed to sink to the bottom, and the supernatant containing fat, connective tissue 
and hair at the top was discarded while being careful not to throw away tissue. The 
beaker was then refilled with CP1, and the previous step of chopping / discarding was 
repeated two more times (i.e. three total times of chopping and pouring off). On the 
last step, instead of adding CP1, 10 milliliters of CP2 (0.1M KCl, 0.05M Tris-HCl, 
2mM EGTA, 0.5% BSA(fatted), 5mM MgCl2, 1mM ATP, Protease Type VIII 
(Sigma P 5380) @ 245.7units/100ml, pH 7.4 @ 4˚C) was added to beaker the for 
every gram of tissue. It is important not to have the CP2 more dilute as this causes 
over digestion of the tissue resulting in a poor yield of mitochondria. Keep in mind 
that CP2 can be made the day before, but the ATP and protease should be added on 
the day of the experiment and the pH rechecked. Also, the solutions should be 
dissolved completely before adding MgCl2.  
The 250mL beaker with tissue suspended in CP2 was left stirring gently on 
ice for 3 min (the timing is very important). The muscle was then allowed to sink to 
the bottom, as much CP2 as possible was poured off, and the beaker was filled with 
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CP1. The tissue was then transferred into approx 20 round-bottom tubes per 
preparation on ice. The Polytron was used on each of the tubes for 20 sec, and the 
supernatant was poured into a 50mL falcon tube. Next, the contents of the falcon tube 
were transferred to a Dounce homogenizer, and care was taken not to transfer large 
chunks. Carefully, the tissue was plunged 5 times with the loose plunger, and 3 times 
with the tight plunger. After each plunge, the chunks of tissue were cleaned off the 
pestle with a Kimwipe. For large volumes of tissue, the homogenization was done in 
two shifts. 
After the tissue had been homogenized, it was spun at 4˚C for 10 min at a 
speed of 490 x g. The supernatant was transferred to a new tub and filtered through a 
70ul cell strainer to remove debris. It was then spun at 4˚C for 10min at 10,368 x g. 
Carefully, the supernatant was discarded and the pellet was re-suspended using a “re-
suspension stick”. The falcon tube containing the sample was then filled with 30ml of 
CP1 and care was taken to make sure the entire sample had been re-suspended. The 
solution was then transferred to a new falcon tube and the last spin step was repeated. 
The supernatant was discarded, the pellet re-suspened, and 180µL of CP1 was added. 
At the end, it is important to make sure there are no clumps of protein before 
determining the protein concentration using the Biuret method (Gornall et al., 1949). 
Isolation of Mitochondria from Heart Muscle 
Mice were sacrificed by cervical dislocation, the hearts were removed and 
immediately placed in ice cold STE (recipe in previous section). In a beaker, the 
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hearts were chopped with scissors and washed with STE until all the blood was 
removed. As much STE as possible was poured off, being careful not to lose any of 
the minced heart tissue, and was replace with 10mL of STE + 20mg Protease Type 
VIII (Sigma P 5380). The suspension was left stirring on ice for 2 minutes. The tissue 
was allowed to sink to the bottom, the supernatant was carefully poured off, and the 
beaker was filled to 70ML with STE. Next, the contents of the beaker were 
transferred to a Dounce homogenizer, plunged 5 times with the loose plunger, and 3 
times with the tight plunger.  
The resulting suspension was centrifuged for 10 minutes at 4˚C at a speed of 
8,000 x g. The supernatant was disposed of and the pellet was re-suspend using a “re-
suspending stick”. All the protease should have remained in the supernatant, thus 
avoiding over-exposure of the mitochondria to the protease. The suspension was 
centrifuged for 10 minutes at 4˚C at a speed of 700 x g, the supernatant was decanted 
into a falcon tube, and the pellet was disposed of. Next, the falcon tube containing the 
supernatant was spun for 10 minutes at 4˚C at a speed of 8,000 x g. Finally, the 
supernatant was disposed of, the pellet re-suspended in ice cold STE, and the protein 
concentration determined using Biuret. 
Isolation of Primary Hepatocytes and Measurement of Basal Metabolic Rate 
Murine primary hepatocytes were isolated according to a slightly modified 
version of the method developed by Seglen (Seglen, 1976). The portal vein was 
cannulated, a suture tied around the cannula, and liver perfusion medium (Invitrogen, 
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17701-038) with 0.01M HEPES buffer added and warmed to 37oC was perfused 
through the liver for 5 minutes. Next, collagenase medium (HBBS w/out phenol red 
from Cellgro, 16mM NaHCO3, 1% FA free BSA, 0.1M HEPES, 0.05% Collagenase 
Type IV – Sigma C5138, pH 7.6 at 37oC) warmed to 37oC was perfused for 5 
minutes. Liver cells were dispersed and gradient centrifuged in isolation media 
(Cellgro DPBS, 1mM sodium pyruvate, 2% FA free BSA, 25mM Dextrose, 0.03M 
HEPES, pH 7.6 at 4oC) according to the aforementioned Seglen method. The isolated 
hepatocytes were switched to incubation medium (106mM NaCl, 5mM KCl, 25mM 
NaHCO3, 0.41mM MgSO4, 10mM Na2HPO4, 2.5mM CaCl2, 10mM glucose, 10mM 
lactate, 1mM pyruvate, 2.25% (w/v) FA free BSA, pH 7.4 at 37oC), and respiration 
was recorded as outlined previously (Harper and Brand, 1993). To determine leak and 
non-mitochondrial respiration, cells were incubated with oligomycin (1.0 ug/ml), and 
myxothiazol (1.0um). 
Measurement of Mitochondrial Respiration 
A Clarke-type oxygen electrode (Dual Digital Model 20, Rank Brothers, UK) 
fitted with a circulating water bath (Model 3016H, Fisher Scientific) was used to 
measure mitochondrial respiration rate. Mitochondria were suspended in either KHEP 
(120uM KCl, 5mM KH2PO4, 3mM HEPES, 1mM EGTA, 0.3% defatted BSA, pH 
7.4) or MRS (70mM Sucrose, 43mM KCl, 3.6mM MgCl2, 7.2mM KH2PO4, 36mM 
Tris-HCl, 0.3% defatted BSA, pH 7.4) at a concentration of 0.5mg/ml and maintained 
at 37oC throughout the recordings. The oxygen solubility of the medium was 
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considered to be 406 nmol/ml (Reynafarje et al., 1985). Rotenone (5µM), Succinate 
(4mM), ADP (1M), Oligomycin (1µg/ml), and FCCP (0.3µM) were added to the 
recording chamber in a stepwise fashion to measure State II, State III, State IV, and 
maximal capacity rates. Data were handled and analyzed using a PowerLab 4/20 data 
recorder and Chart Pro Software (both from AD Instruments, CO). 
Modular Kinetic Analysis 
The kinetics of proton leak, substrate oxidation, and ATP turnover were 
determined as described previously (Brand, 1995; Brand et al., 1993; Hafner et al., 
1990; St-Pierre et al., 2003). Mitochondrial membrane potential was measured using 
a methyltriphenylphosphonium (TPMP+) electrode as described earlier (Brown and 
Brand, 1985), using a TPMP+ binding correction of 0.54. Mitochondria were 
incubated at a concentration of 0.5mg/ml in KHEP assay medium (composition in 
previous section), and maintained at 37oC throughout the assay. For proton leak and 
substrate oxidation kinetics, rotenone (5µM), oligomycin (1µg/ml), and nigericin 
(0.11 µM) were present at the beginning of each run. For ATP turnover kinetics, 
rotenone (5µM), nigericin (0.11 µM), and ADP (0.57mM) were present at the 
beginning of each run. TPMP+ was then added up to 1.3µM for calibration, and 
succinate (4mM) was fed to the mitochondria as a substrate. Either malonate (proton 
leak, and ATP turnover) or FCCP (substrate oxidation) was then gradually added to a 
concentration of 1.3mM or 0.85µM, respectively, to reduce the membrane potential. 
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At the end of each recording, 1.1µM FCCP was added to determine the drift of the 
electrode, if any. 
Protein isobaric labeling with iTRAQ reagents 
 Mitochondria were solubilized with 7 M urea, 2 M thiourea and 100 mM N-
octyl-β-D-glucopyranoside and protein concentration determined. Protein (60-100 ug) 
was precipitated with acetone (90% final, v/v) at -20oC overnight. For the four-plex 
isobaric labeling, separate mitochondrial preparations containing equal amounts of 
protein were treated in parallel essentially as described by (Ross et al., 2004). Stock 
reagents and buffer (TEAB, SDS, TCEP, MMTS and four isobaric tagging reagents) 
are obtained in kit form (Applied Biosystems). Protein (60-100 µg protein) was 
suspended in 20 ul 0.5 M TEAB, reduced with 2.5 mM TCEP (40oC for 1 h) and 
cysteine residues blocked with 10 mM MMTS (room temperature for 15 min). 
Proteolytic digestion was with trypsin (porcine modified, Promega; 1:20, w/w) for 20 
h at 40oC. Isobaric tagging iTRAQ reagent (1 unit1 in ethanol) was added directly to 
the protein digest (70% ethanol, v/v, final) and the mixture incubated at room 
temperature for 1h. The reaction was quenched by addition of 9 volumes 0.1% TFA 
in water (Optima grade, Fischer Sci.). The reaction mixtures are combined and stored 
at -20oC. Mitochondrial protein from wt (sham), wt (leptin treated), ob (sham) and ob 
(leptin treated) animals were isobarically labeled with 114.1, 115.1, 116.1 and 117.1 
iTRAQ reagent, respectively, in all experiments.  
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SCX Peptide Fractionation  
 The iTRAQ four-plex-labeled peptide mixture (400, 252 and 276 µg digest for 
experiments A, B and C, respectively) was applied to a pair of sulfoethyl aspartamide 
SCX spin columns (SEM HIL-SCX, PolyLC, The Nest Group, Inc. Southboro, MA) 
equilibrated with 10 mM KH2 phosphate, pH 4.5, 20 % CH3CN. For peptide 
adsorption to the column and subsequent washing and elution steps, a centrifugal 
force of 400 x g was used.  Excess reagent was washed from the column with 800 µl 
equilibration buffer. Peptides were eluted with eight 50 µl volumes of KCl in a 
stepwise gradient from 50-500 mM KCl in equilibration buffer (i.e. 50, 80, 115, 155, 
180, 205, 350 and 500 mM KCl) and fractions were dried in a vacuum centrifuge. 
Reverse Phase LC 
 Peptides in SCX fractions were separated by C18 nano LC using an 1100 
Series nano HPLC equipped with µWPS autosampler, 2/10 microvalve, MWD uv 
detector (214 nm) and Micro-FC fraction collector/spotter (Agilent). Each SCX salt 
step was reconstituted with 43 ml 0.1 % TFA, v/v in water and 40 µl injected. Digest 
was trapped on a C18 cartridge (Zorbax300SB, 5 µm, 5 x 0.3 mm; Agilent), desalted 
with solvent C (CH3CN:H2O:TFA, 5:95:0.1) at 20 µl/min for 9 min. and effluent 
directed to waste. At 9 min post injection,the trapping cartridge was placed ahead of a  
C18 column (Zorbax300SB, 3.5 µm, 150 x 0.1 mm; Agilent) equilibrated with solvent 
A (H2O:TFA, 99.9:0.1). Peptides were eluted with a gradient of solvent B 
(CH3CN:H2O:TFA, 90:10:0.1) from 6.5% B to 50% B over 90 min at a flow rate of 
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0.4 µl/min. Column effluent was mixed (micro Tee, Agilent) with matrix (2 mg/ml α-
CHCA in CH3OH:isopropanol:CH3CN:H2O:acetic acid (12:33.3:52:36:0.7) 
containing 10 mM ammonium phosphate) delivered with a PHD200 infusion pump 
(Harvard Apparatus) at 0.9 µl/min. Fractions were spotted at 24 sec. intervals onto 
stainless steel maldi targets (192 wells/plate, Applied Biosystems).  
Mass Spectrometry 
 Mass spectra were acquired on an Applied Biosystems 4800 Maldi TOF/TOF 
Analyzer (TOF/TOF). MS spectra from 800-3500 Da were acquired for each fraction 
from 750 laser shots of a 200 Hz YAG laser operated in the 3rd harmonic (355 nm). 
The TOF/TOF was operated in positive ion reflectron mode. Seven point Gaussian 
smoothing was applied to spectra and S/N of 30 filter applied for peak picking. 
Calibration was done using default mode. Plate calibrants were glu-fibrinopeptide A 
(m/z 1714.787), ACTH (m/z 2753.419), angiotensin (m/z 1440.790), bradykinin (m/z 
1048.578), and ACTH 1-17 (m/z 2107.197). The twelve most intense peaks in each 
MS spectrum were selected for MS/MS analysis. MSMS spectra were acquired from 
1500-4000 laser shots using “quality dependent” mode (6 fragment ions at S/N  60); 
fragment peak picking used S/N 40. MSMS calibration was done with fragments of 
glu-fibrionpeptide A (m/z 430.242, 684.346, 1056.475 and 1441.634). In a re-
interrogation of the target plates, additional MS/MS spectra were acquired. 
Fragmentation of the labeled peptides was induced by the use of atmosphere as a 
collision gas with a pressure of ~ 6 x10-7 torr and a collision energy of 2kV.  
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Peptide identifications were performed using GPS Explorer (v3.6, Applied 
Biosystems) which acts as a front end for the Mascot search engine (v2.1 
MatrixScience, London UK).  Each MS/MS spectrum was searched against IPI 
mouse. Trypsin specificity with one missed cleavage was selected. S-
mercaptomethylcysteine and the N-terminal and lysine iTRAQ labels were selected as 
fixed modifications. Oxidized methionine was considered as a variable modification. 
The precursor tolerance and MS/MS fragment tolerances were set to +/- 0.7 and +/- 
0.3 Da, respectively. A confidence interval (C.I.%) was calculated by GPS Explorer 
using Mascot ion score and significance, such that a C.I.% value of 95% is equivalent 
to a Mascot ion score at the significance value. The individual peptide identifications 
were grouped into protein identifications and assigned a total ion C.I.% by GPS 
Explorer. 
Liver Triglyceride Levels 
Total lipids were extracted from liver as described in previously established 
protocols (Bligh and Dyer, 1959). Quantification of fatty acids was done through 
liquid chromatography in accordance to previously published methods (Asilmaz et 
al., 2004; Miyazaki et al., 2001). For the quantification of fatty acids, pentadecanoic 
acid (Sigma-Aldrich) was added as an internal standard. 
Mitochondrial Volume Density and Area Measurements 
The unbiased stereological method for the assessment of mitochondrial 
density was used based upon our published paper (Coppola et al., 2007). The central 
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feature of this approach is the use of a systematic random sampling method, which 
meets the statistical requirements necessary to insure an unbiased estimate of the 
feature of interest.  The estimation was performed using the Cavalieri method 
(Gundersen et al., 1988; Gundersen and Jensen, 1987) and the optical dissector 
method. The assessment of mitochondrial number was determined using the optical 
dissector method on electron micrographs.  One-way analysis of variance was 
performed followed by the Student-Newman-Keuls-test to determine significance of 
differences between groups. The statistical confidence was set at P < 0.05. 
Lipid Quantification from Purified Hepatic Mitochondria 
Samples were isolated by sequential ultracentrifugation. The mitochondrial 
fraction from each sample was re-suspended in 200 µL of 50% chloroform and 
methanol (v/v). Twenty µL of sample was analyzed by normal phase HPLC-MS. 
Lipids were separated on a SUpelcosil –LC-Si column (1 mm * 30 cm; SUPELCO) 
on the HP1100 HPLC/ABI QSTAR XL LC/MS system, with ion extraction, 
separation, and detection in both positive and negative ion modes. The solvents were 
5 mM ammonium acetate in chloroform/MeOH/(IPA)/water (80:10:7:3) (A) and 5 
mM ammonium acetate in MeOH/IPA/water(90:7:3) (B). Data were acquired using 
information-dependent, automated acquisition. The acquired ms/ms spectra were 
analyzed to determine the lipid classes and relative quantities. 
General Steps and Lipid Extraction for Measurement of Oxidated Fatty Acids 
The Hazen Lab at the Cleveland Clinic carried out this procedure in 
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collaboration with our lab. The methods described in this and the next section 
discussing measurement of oxidated fatty acids are incorporated from their previously 
published methods (Zhang et al., 2002). Free fatty acids were purchased from 
Cayman Chemical Company (Ann Arbor, MI). Organic solvents were obtained from 
Fisher Scientific Co. (Pittsburgh, PA). All other reagents were purchased from Sigma 
unless otherwise indicated. All buffers were passed over a Chelex-100 resin column 
(Bio-Rad) and supplemented with 0.1 mM diethylenetriamine pentaacetic acid 
(DTPA) to remove potential contaminant transition metal ions that might catalyze 
lipid oxidation. Protein content was determined using Bradford-based Bio-Rad 
protein assay using IgG as protein standard. 
Lipid extraction was carried out next. All steps were performed under either 
argon or nitrogen atmosphere. Immediately prior to extraction, 10 ng each of two 
deuterated internal standards, 12(S)-hydroxy-5,8,10,14-eicosatetraenoic- 
5,6,8,9,11,12,14,15-d8 acid (12-HETE-d8) and prostaglandin F2  (PGF2 -d4) 
(Cayman Chemical Company) were added to each sample. Hydroperoxides in 
samples were then reduced to their corresponding stable alcohols by adding 1 mM 
SnCl2 (23). Lipids were then extracted by adding a solvent mixture (1 M acetic 
acid/2-isopropanol/hexane (2:20:30, v/v/v) to the sample at a ratio of 2.5 ml of 
solvent mixture/1 ml of sample, vortexing, and then adding 2.5 ml hexane. Following 
vortex and centrifugation, lipids were recovered in the hexane layer. Peritoneal 
lavages were re-extracted by addition of an equal volume of hexane, followed by 
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vortex and centrifugation. The combined hexane layers were dried under N2 flow and 
then analyzed following saponification to release all esterified fatty acid oxidation 
products. For saponification, N2-dried lipids were resuspended in 1.5 ml of 2-
isopropanol, and then fatty acids were released by base hydrolysis with 1.5 ml of 0.2 
M NaOH at 60 °C for 30 min under argon atmosphere. Hydrolyzed samples were first 
acidified to pH 3.0 with 0.5 M HCl, and then fatty acids were extracted twice with 4 
ml of hexane. The combined hexane layers were dried under N2 flow, resuspended in 
100  l of methanol, and stored under argon at  80 °C until analysis by reverse phase 
high performance liquid chromatography (HPLC) with on-line electrospray ionization 
tandem mass spectrometry (LC/ESI/MS/MS), as described in the next section. 
Lipid Analysis for Measurement of Oxidated Fatty Acids 
LC/ESI/MS/MS was employed to quantify the multiple distinct oxidation 
products of arachidonic acid and linoleic acid, including individual HETEs, F2-
isoprostanes, and hydroxy-octadecadienoic acids (HODEs). Immediately prior to 
analysis, one volume of H2O was added to 20 volumes methanol-suspended sample, 
which was then passed through a 0.22- m filter (Millipore Corporation, Bedford, 
MA). Sample (50  l) was injected onto a C-18 column (2   250 mm, 5  m ODS) 
(Phenomenex, Rancho Palos Verdes, CA) at a flow rate of 0.2 ml/min. The separation 
was performed using a gradient starting from 85% methanol over 15 min, then to 
100% methanol over 1 min, followed by 100% methanol for 15 min. HPLC column 
effluent was split so that only 50% was introduced into a Quattro II triple quadrupole 
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mass spectrometer (Micromass, Inc.). 
Analyses were performed using electrospray ionization in negativeion mode 
with multiple reaction monitoring of parent and characteristic daughter ions specific 
for each isomer monitored. The transitions monitored were mass-to-charge ratio 
(m/z): m/z 295 3 171 for 9-HODE; m/z 2953195 for 13-HODE; m/z 2793261 for 
linoleic acid; m/z 3193115 for 5-HETE;m/z 3193155 for 8-HETE;m/z 3193151 for 9-
HETE;m/z 319 3 167 for 11-HETE; m/z 319 3 179 for 12-HETE; m/z 319 3 175 for 
15-HETE; m/z 303 3 259 for arachidonic acid; m/z 327 3 184 for 12-HETE-d8; m/z 
353 3 309 for F2-isoprostanes; and m/z 357 3 313 for PGF2 -d4. The nitrogen curtain 
gas-flow rate was 5 liters/min and nebulizer gas-flow rate was held at 0.2 liters/min. 
Collision-induced dissociation was obtained using argon gas. The internal standard 
12-HETE-d8 was used to for quantification of HETEs as well as to calculate 
extraction efficiencies of HODEs and HETEs (which were   85%). The internal 
standard PGF2 -d4 was used to for quantification of F2-isoprostanes. 
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 Chapter 3: Results 
Quantitation of Leptin’s Effects on Thermogenesis and Metabolism 
Resting core body temperature in leptin deficient ob/ob mice is significantly 
lower than in their wild-type control littermates, and leptin treatment of these mutant 
mice restores their core body temperature to normal/wild-type levels (Figure 9A). 
This indicates that a proportion of leptin’s metabolic effects in ob mice are a result of 
increased thermogenesis and subsequent restoration of core body temperature. In 
order to assess whether there are metabolic effects in addition to this, we treated a 
second group of ob mice with leptin under thermoneutral conditions. Ob/ob mice 
housed at 30oC, the temperature at which metabolic energy is not required to maintain 
core temperature (Gordon, 1993), have core body temperatures that are not 
significantly different from their littermates controls. Leptin treatment of ob/ob mice 
housed at this temperature does not significantly alter core body temperature (Figure 
9A). 
In order to test whether leptin has additional metabolic effects under these 
conditions, we compared the effects of leptin treatment to pair feeding of ob/ob mice 
at both 22oC and 30oC. The group treated with leptin at 22oC followed the established 
trajectory of weight loss (Halaas et al., 1995), and lost fat mass equivalent to 36.5% 
of their body weight in two weeks (Figure 9B). In comparison, mice pair fed at 
thermoneutral temperatures lost 13.8% of their body weight during the same time 
period, indicating that approximately two fifths of leptin-mediated weight loss is due 
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Figure 9. Components of leptin mediated weight loss. (A) ob/ob mice
have a lower core body temperature than wt mice, which is corrected by
leptin infusion. Housing the mice at thermoneutral temperatures increases
the core body temperature of ob/ob mice and diminishes the significance of
body temperature correction by leptin. (B) By leptin treating and pair feeding
mice at room and thermoneutral temperatures, we were able to distingush
the different components of leptin mediated weight loss. Arrow 1 represents
weight loss due to leptin's correction of body temperature. Arrow 2
represents weight loss due to leptin's induction of satiety. Arrow 3 represents
wight loss due to leptin mediated increases in energy expenditure and basal
metabolic rate.
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to the induction of satiety (Figure 9B, arrow 1). Leptin treated animals housed at 22oC 
lost 12% more weight than animals receiving the hormone at 30oC. Similarly, pair fed 
animals housed at 22oC also lost 12% more weight than animals receiving the same 
treatment at 30oC. These findings suggest that approximately one third of leptin-
mediated weight loss is due to the normalization of body temperature (arrow 2). 
Another observation we made was that leptin treated animals lost 11% more weight 
than pair fed animals when housed at 22oC. Leptin treated animals housed at 30oC 
also lost 11% more weight than their pair fed counterparts. These findings indicate 
that the remaining one third of leptin-mediated weight loss is due to increases in 
energy expenditure and basal metabolic rate (arrow 3) (p<0.0001 for all 
comparisons). 
Having shown that leptin has metabolic effects beyond normalizing core 
temperature, we next set out to analyze which tissues contribute to the increased 
energy expenditure discussed above. We started our investigation with the liver 
because of several reasons. First of all, the organ plays an integral role in lipid 
metabolism (Bell, 1979). Secondly, the liver is responsible for approximately 20% of 
the standard metabolic rate (SMR), and thus has significant energy demands (Porter 
and Brand, 1993). Finally, the liver is known to be an integral player in some of the 
catabolic effects of leptin (Cohen et al., 2002). Therefore, the liver made a good 
candidate organ for the location of the changes in metabolism we were interested in 
investigating further. 
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Livers from ob mice are markedly steatotic  and 12 days of leptin treatment at 
ambient temperature corrects this abnormality (Figures 10A and 10B).  In order to 
determine the mechanisms by which leptin carries out this correction, we measured 
the liver triglyceride (TG) levels of leptin treated and pair fed ob mice housed at both 
22oC and 30oC. Animals receiving leptin treatment at 22oC had liver triglyceride 
levels of 439µM/g, as opposed to 670µM/g for those treated with the hormone at 
30oC (Figure 10C). Likewise, animals pair fed at 22oC had liver triglyceride levels of 
664µM/g, as opposed to 906µM/g for those receiving the same treatment at 30oC. 
These data suggest that the steatosis was in part corrected by leptin-mediated 
normalization of body temperature (p<0.01) (Figure 10C, arrow1). Furthermore, 
leptin treatment at 22oC reduced liver triglyceride levels by approximately 225µM/g 
over pair feeding at the same temperature (439µM/g vs. 664µM/g) (Figure 10C). 
Similarly, leptin treatment at 30oC reduced liver triglyceride levels by approximately 
236µM/g over pair feeding (670µM/g vs. 906µM/g). These findings indicate that the 
steatosis is also corrected in part by leptin-mediated increases in energy expenditure 
and basal metabolic rate (p<0.01). 
Leptin Levels Influence Hepatocyte Metabolism 
 Since our data showed a role for leptin-mediated increases in energy 
expenditure in the liver, we wanted to see if we could measure such changes. 
Therefore, we analyzed the effects of leptin pre-treatment on freshly isolated primary 
hepatocyte metabolism. Each day recordings were made from one ob/ob + lep animal 
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Figure 10. Leptin-Mediated Correction of Hepatic Steatosis. (A) Ob/ob mice have livers
exhibiting severe steatosis, which is amended by leptin restoration for 12 days (B). (C)
Leptin-mediated correction of hepatic steatosis has one component which is correlated with
leptin's correction of body temperature (Arrow 1), and another with leptin-mediated increases
in energy expenditure (Arrow 2).
60
and one ob/ob + pbs animal. To correct for daily variances in recordings due to 
differences in the freshly made solutions, membrane permeability, and variable 
precipitation on the electrodes, we normalized the data by dividing the values from 
both groups by the total respiration recorded for that day. This gave us a “normalized 
ratio” that we could use to compare the rates between the leptin treated and pbs 
treated groups on different days. 
Twelve-day leptin treatment of ob/ob mice reduces the primary hepatocyte 
basal metabolic rate normalized ratio from 0.63 to 0.37 (Figure 11A) (p<0.0001). The 
addition of oligomycin to the solution inhibits Complex V of the mitochondrial 
electron transport chain, and stops coupled respiration – i.e. respiration that results in 
the formation of ATP. In this scenario, since coupled respiration has been halted, any 
respiration that is recorded is due to uncoupled respiration, more commonly referred 
to as mitochondrial leak. Upon addition of oligomycin in our recordings, the leak 
component of primary hepatocyte basal metabolic rate is reduced from 64.8% to 
41.7% with leptin treatment (Figure 11B)(p<0.05). These findings indicate that there 
is a leptin-mediated reduction in the amount of uncoupled respiration. At the end of 
each recording, we add myxothiazol to determine the non-mitochondrial respiration 
in the hepatocytes so it can be corrected for in the respiration rates (See methods). 
However, when we look at the non-mitochondrial respiration itself, we see 
differences between the two treatment groups. Twelve-day leptin treatment of ob/ob 
mice reduced the non-mitochondrial oxygen consumption normalized ratio in primary 
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Figure 11. Primary Hepatocytes from ob/ob mice plus/minus
leptin. (A) Twelve day leptin treatment of ob/ob mice reduces primary
hepatocyte basal metabolic rate. (B) The leak component of basal
metabolic rate, i.e. uncoupled respiration, is also decreased with leptin
treatment. (C) Finally, leptin treatment decreases non-mitochondrial
respiration as well. = p < 0.05
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hepatocytes from 0.79 to 0.21 (p<0.01). Therefore, leptin is having affects on both 
mitochondrial and non-mitochondrial respiration, which is further explored in the 
discussion section that follows. 
Leptin Inhibits Hepatic Mitochondrial State Two, Four, and FCCP Rates 
To test what effects the observed leptin-mediated changes in primary 
hepatocyte metabolism may be having on mitochondria in these cells, we measured 
the different components of mitochondrial respiration. Since we had demonstrated 
that mitochondrial leak was affected in the hepatocytes treated with leptin, we first 
wanted to look at the respiratory control ratio (RCR) of hepatic mitochondria. This 
measure is the ratio of coupled respiration over uncoupled respiration (i.e. leak). RCR 
is lower in ob/ob mice (2.43) than in wt mice (4.64) (p<0.05) (Figure 12). This 
difference disappears with leptin treatment of the ob/ob animals, as the RCR of leptin 
treated ob/ob mice (5.58) is significantly higher than that of saline treated ob/ob mice 
(2.43) (p<0.01). 
To determine the cause underlying these changes in RCR, we measured state 
two, three, four, and respiratory capacity rates. State two and four rates give insight 
into the leak component of respiration, while state three and respiratory capacity rates 
provide insight into the coupled component of respiration. Our recordings showed 
that state two rates were higher in ob mice (55.3 nmolO2/min/mg mito) than in wild-
type mice (28.9 nmolO2/min/mg mito)(Figure 13A)(p<0.05). Leptin treatment of the 
ob/ob mice reduced the state two rates down to 39.8 nmolO2/min/mg mito, and thus 
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Figure 12. Liver mitochondria RCR analysis from Ob/Ob and Wt
mice plus/minus leptin. Respiratory control ratio (RCR) is lower in MRS
+ BSA media in ob/ob and the effect is reversed by leptin infusion. n=5 for
all points, and each was done in duplicate.
= p < 0.01 ; = p < 0.05
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Figure 13. Liver mitochondria leak analysis from Ob/Ob and Wt
mice plus/minus leptin. (A) State 2 and (B) State 4 rates are higher in
ob/ob mice, which initially suggested that a higher proton leak in ob/ob
may be the cause behind the observed changes in the RCR. n=5 for all
points, and each was done in duplicate. , = p < 0.01 ; , = p < 0.05
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diminished the difference between ob/ob and wild-type mice. State four rates are also 
higher in ob mice (116.0 nmolO2/min/mg mito) than in wt mice (41.9 
nmolO2/min/mg mito). Similar to its effects on state two rates, leptin treatment of 
ob/ob mice reduces state four rates to 44.36 nmolO2/min/mg mito, thus bringing them 
to wild-type levels. These initial data suggest that a higher proton leak in ob/ob mice 
may be the cause behind the observed differences in the RCR. Since an increased leak 
in ob/ob animals that is reduced to wild-type levels with leptin treatment is the 
opposite of what we would have expected, and since both state two or four rates come 
with caveats regarding their interpretation, we conducted modular kinetic analysis to 
study these rates in closer detail in the next section. 
Having taken a closer look at the denominator of RCR, i.e. uncoupled 
respiration, we wanted to take a look at the numerator, coupled respiration. As 
mentioned earlier, state three and FCCP rates provide insight into this component of 
respiration, and were thus studied next. State three rates are not significantly different 
between ob/ob and wt animals, and do not change with leptin treatment (Figure 14A). 
Slight differences seem to be present in the means of the rates between the groups, 
and perhaps with more repeats these would become significant. On the other hand, 
FCCP rates, which represent mitochondrial respiratory capacity, are higher in ob/ob 
mice (232.8 nmolO2/min/mg mito) than in wild-type mice (166.0 nmolO2/min/mg 
mito)(Figure 14B) (p<0.01). Leptin treatment of the ob/ob mice reduces FCCP rates 
to 199.1 nmolO2/min/mg mito, and thus diminishes the difference between ob/ob and 
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Figure 14. Liver mitochondria substrate oxidation analysis from
Ob/Ob and Wt mice plus/minus leptin. (A) State 3 and (B) FCCP rates
decrease with leptin treatment, suggesting that the hormone may have
effects on the substrate oxidation system. n=5 for all points, and each
was done in duplicate. , = p < 0.01 ; , = p < 0.05
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wild-type animals. These data suggest that ob/ob mice have a higher substrate 
oxidation capacity, which is reduced to wild-type levels with leptin treatment. This 
possibility is explored further in the next section, where the results of modular kinetic 
analysis into substrate oxidation capacity are presented. 
Since no in vitro study can exactly replicate physiological conditions in vivo, 
the artificial environment created by different recording solutions can greatly affect 
observed mitochondrial respiration rates. Bovine serum albumin (BSA) was present 
in the recording solution we were using for the recordings described above. The logic 
behind this was that BSA removes free fatty acids that are in the solution, which can 
interact with mitochondria to change the inner membrane potential. Though the 
removal of these free fatty acids is most likely beneficial to our recordings, we didn’t 
know exactly what affect it may be having on the respiration rates. For this reason we 
did recordings with a solution that was exactly the same as the one used above, except 
it was missing BSA. In these recordings we found that the respiratory control ratio 
(RCR) was still significantly lower in ob/ob animals as compared to their wild-type 
littermates (Figure 15A)(p<0.05). Furthermore, leptin treatment also normalized 
ob/ob rates back to wild type levels in this solution without BSA. Similarly, state two 
and four rates were significantly lower in wild-type versus ob/ob mice (p<0.05 and 
p<0.01, respectively), and were both brought towards wild-type levels in leptin 
treated ob/ob mice (Figure 15B and C). Since these results are similar to those 
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Figure 15. Liver mitochondria respiratory analysis from Ob/Ob
and Wt mice plus/minus leptin without BSA in solution. (A) RCR,
(B) State II respiration, and (C) FCCP rates are not affected by the
presence (Figure 14) or absence (Figure 15) of BSA in the recording
solution, suggesting that free fatty acids are most likely not affecting
recording rates. n=5 for all points, and each was done in duplicate. =
p < 0.01 ; = p < 0.05
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observed in the solution containing BSA, we can conclude that BSA is most likely 
not affecting our recordings in any significant way. 
In our efforts to be thorough with the hepatic mitochondrial recordings, we 
had come across two commonly used recording solutions. As discussed above, the 
composition of the solution used can have a great impact on the rates one records, and 
thus we wanted to see if there were any differences when recording with this second 
solution. RCR recordings done in the new solution, called KHEP solution (details in 
methods section), did not show a difference between ob/ob mice and wild-type mice 
(Figure 16A). Furthermore, we did not observe a change in RCR with leptin treatment 
of ob/ob mice when recording from mitochondria in this solution. Similar to the 
results seen in the other two solutions, state two respiration was significantly lower in 
wild-type mice as compared to ob/ob mice (Figure 16B)(p<0.01), a difference that 
was reduced with leptin treatment of the ob/obs. Furthermore, FCCP rates were also 
significantly lower in wild-type mice as compared to ob/ob in the KHEP solution 
(Figure 16C)(p<0.01). This difference was slightly reduced with leptin treatment, to 
the point where it became statistically insignificant. Thus in the KHEP solution, RCR 
rates look different than they do in the other solutions, while state two and FCCP 
rates look similar to those seen before. 
Leptin Inhibits the Hepatic Substrate Oxidation System 
To further explore the leptin-mediated changes in mitochondrial leak and 
substrate oxidation capacity discussed above, we conducted modular kinetic analysis. 
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Figure 16. Liver mitochondria respiratory analysis from Ob/Ob
and Wt mice plus/minus leptin in KHEP solution. Since there are
two mainstream recording solutions used for mitochondrial
respiration recordings, we wanted to check if our findings are seen in
both. (A) The previously observed leptin-mediated changes in RCR
are not seen in KHEP recording solution. (B) State II respiration, and
(C) FCCP rates are still reduced with leptin treatment, suggesting
that the change in solution had little effect on them.. n=5 for all
points, and each was done in duplicate. = p < 0.01 ; = p < 0.05
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In these studies, mitochondrial oxygen consumption is measured with a Clarke 
electrode, while the mitochondrial inner membrane potential is measured with a 
TPMP electrode simultaneously (see methods). This allows one to plot changes in 
respiration as a function of membrane potential, which gives insight into the kinetics 
underlying mitochondrial respiration rates. Since one can fully appreciate the inner 
workings of mitochondrial respiration through this method, it is considered to be the 
“gold standard” of recordings. The difficulties in conducting these recordings attest to 
the general preference for the use of state two, three, four and FCCP rates instead, 
which in most cases are sufficiently thorough. In our case, however, we wanted to 
explore the leak and substrate oxidation findings further, and thus turned to modular 
kinetic analysis. 
 In the first set of recordings, we blocked the phosphorylation system with 
oligomycin, and induced an increase in leak with a titration of FCCP. This causes the 
proton gradient across the inner mitochondrial membrane to dissipate, and we can see 
how these changes affect the substrate oxidation system. When we conducted these 
recordings, we found that the substrate oxidation system is increased in ob/ob mice in 
comparison to wt mice (Figure 17). Twelve-day leptin treatment of these ob/ob mice 
reduces the substrate oxidation capacity of their hepatic mitochondria back towards 
wild-type levels. These findings can account for the changes in FCCP rates observed 
in the previous section. 
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Figure 17. Modular  Kinetic Analysis of Leptin's Actions in Hepatic Mitochondria. The substrate 
oxidation system is increased in ob/ob and partially reversed by leptin. n=5 for all points, each 
done in duplicate.
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In the second set of recordings, we blocked the phosphorylation system with 
oligomycin like before, but this time we titrated with malonate to block the substrate 
oxidation system. This again caused the proton gradient across the inner 
mitochondrial membrane to dissipate, and we could see how these changes affected 
mitochondrial proton leak. Our recordings show that hepatic mitochondrial leak is not 
different between ob/ob mice and wild-type mice (Figure 18A). Furthermore, leptin 
treatment does not change mitochondrial leak as the previously recorded state two 
and four respiration rates had indicated. The reason behind the observed differences is 
further elaborated upon in the discussion section. 
Finally, in the last set of recordings, we just titrate with malonate to block the 
substrate oxidation system. Once again, this causes the proton gradient across the 
inner mitochondrial membrane to dissipate. Since there is no blockage of proton leak 
in this case, our recordings will show the dependence of both leak and the 
phosphorylation system on the mitochondrial inner membrane proton gradient. By 
subtracting the leak observations from these recordings, we can study the 
phosphorylation system in isolation. Our recordings show that the hepatic 
mitochondrial phosphorylation system is not different in ob/ob mice as compared to 
wild-type mice (Figure 18B). Furthermore, leptin treatment does not affect this 
system in either ob/ob or wild-type mice. 
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Figure 18. Modular  Kinetic Analysis of Leptin's Actions in Hepatic Mitochondria. Neither the 
leak (A) nor the phosphorylation system (B) change with leptin treatment of ob/ob mice. n=5 
for all points, each done in duplicate.
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Leptin’s Effects on Liver Metabolism Are Independent of its Effects on Hepatic 
Fat Stores 
Leptin’s effects on the components of liver metabolism of ob/ob mice 
discussed above could be the result of its ability to correct steatosis and/or a 
consequence of normalizing circulating leptin levels.  To distinguish between these 
possibilities, we employed a leptin protocol study, in which wild-type mice were 
given high doses of leptin (2.5mg/hour) for eight days to completely deplete their fat 
reserves.  Upon the cessation of leptin treatment, the mice were divided amongst two 
groups: free fed (FF) and normo-caloric (NC).  The FF animals were allowed to 
consume as much food as they wanted to for the next seven days - they quickly 
regained their fat mass and restored normal levels of circulating leptin.  Each NC 
animal was fed the same amount of food it had consumed while on leptin treatment 
for the seven days after leptin withdrawal - these mice became hypoleptinemic as 
they could not produce the hormone themselves without adipose tissue.  A group of 
littermates were infused with, and withdrawn from PBS alongside the leptin groups to 
serve as a further control.  Since wild-type mice do not develop hepatic steatosis, this 
study allowed us to analyze the effects of leptin deficiency independently of any 
changes resulting from the treatment of hepatic steatosis. 
In this study, the RCR was not significantly different in the hepatic 
mitochondria of hypoleptinemic NC mice as compared to PBS treated controls 
(Figure 19). Furthermore, the re-establishment of leptin levels in the FF mice did not 
cause a difference in RCR to arise. These results call for further investigation into 
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Figure 19. Liver mitochondrial RCR from wt mice with/without
hypoleptinemia. To determine whether the observed change in substrate
oxidation kinetics (figure 17) is a secondary response to steatosis, attempting to
increase ox phos rates in the face of compromised fatty acid oxidation, we looked
at miotchondria from mice with hypoleptinemia but not steatosis. Our results show
that RCR is not lower in hypoleptinemic "Wt Lep NC" mice, unlike ob/ob mice. This
calls for further investigation into the components of RCR, which is shown in the
next figure. n=5 for all points, and each was done in duplicate.
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coupled and uncoupled respiration rates in order to determine the differences between 
leptin’s actions in the presence or absence of hepatic steatosis. 
Looking at uncoupled respiration, we found that state two rates were not 
significantly different in hypoleptinemic NC mice as compared to PBS treated 
controls (Figure 20A). Furthermore, these rates were not changed by the re-
establishment of circulating leptin levels in the FF mice. Similarly, state four rates 
were also not significantly different in the NC mice (Figure 20B). Again, the FF mice 
did not show any differences when compared to both the NC and PBS groups. Thus 
under conditions where hypoleptinemia does exist but hepatic steatosis does not, there 
is no evidence of a change in proton leak with leptin treatment. These results are 
consistent with the data obtained by modular kinetic analysis of ob/ob mice in the 
previous section. 
We next turned our attention to the numerator of RCR, i.e. coupled 
respiration, in these hypoleptinemic mice. State three respiration rates were not 
different in NC mice versus PBS mice, and leptin normalization in the FF mice did 
not alter these rates either (Figure 21A). However, similar to leptin treatment of ob/ob 
mice, the oxygen consumption in the presence of FCCP was significantly higher in 
hypoleptinemic mice (186.1 nmolO2/min/mg mito) versus that in PBS treated controls 
(152.0 nmolO2/min/mg mito)(Figure 21B)(p<0.01). Furthermore, re-establishment of 
circulating leptin levels in FF mice reduced the FCCP rates back down to PBS treated 
levels (154.0 nmolO2/min/mg mito)(p<0.01). These data show that in the case of 
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Figure 20. Liver mitochondrial leak from wt mice with/without hypoleptinemia.
Neither State 2 (A) nor state 4 (B) rates are different in hypoleptinemic mice, so there
is no sign of changes in proton leak. This is similar to observations in ob/obs. n=5 for
all points, and each was done in duplicate. , = p < 0.01
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Figure 21. Liver mitochondrial substrate oxidation from wt mice
with/without hypoleptinemia. Though State 3 rates do not change (A), FCCP
rates are higher in hypoleptinemic mice, and decrease upon restoration of
leptin levels (B). This is similar to the leptin-mediated decrease in the substrate
oxidation system seen in ob/ob mice. Therefore, we can conclude that leptin's
control over the hepatic mitochondrial substrate oxidation system is most likely
independent of its effects on hepatic fat stores. n=5 for all points, and each was
done in duplicate. , = p < 0.01
80
hypoleptinemia without the presence of hepatic steatosis, mitochondrial respiratory 
capacity is still significantly reduced. Furthermore, re-establishment of leptin levels 
without any change in hepatic fat stores still significantly decreases the mitochondrial 
respiratory capacity down towards wild-type levels. Since the effects of leptin in this 
study on both uncoupled and coupled respiration were the same as what was recorded 
during modular kinetic analysis of ob/ob mice, these data suggest that leptin’s effects 
on hepatic metabolism are not secondary to its ability to reduce hepatic lipid content. 
Leptin Levels Influence Mitochondrial Morphology 
Mitochondrial morphology is closely linked to the metabolic state of the 
organelle, and can give great insight into its function. The observation that leptin 
modulates mitochondrial metabolism led us to next assess mitochondrial morphology 
and mass before and after leptin treatment using electron microscopy on PBS treated, 
leptin treated, and pair fed ob/ob mice. The mitochondria of 12-day PBS treated 
ob/ob mice have both normal cristae structure and morphology (Figure 22). A total of 
54 micrographs from n=5 mice were studied and yielded similar results. Similarly, 
the mitochondria of 12-day pair fed ob/ob mice also had normal cristae structure and 
morphology (Figure 23). In this case, 53 micrographs from a total of n=5 mice were 
studied and yielded similar results. Interestingly, the mitochondria of 12-day leptin 
treated ob/ob mice (Figure 24) were morphologically different from both control 
groups and exhibited a less dense, “ballooned” appearance compared to those of 12-
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Figure 22. Electron Microscopic Analysis of Hepatic Mitochondrial
Structure. Mitochondria in the hepatocytes of PBS treated ob/ob mice 
have both normal cristae structure and density. A total of 54 
micrographs from n=5 mice were studied and yielded similar results.
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Figure 23. Electron Microscopic Analysis of Hepatic Mitochondrial
Structure. Mitochondria in the hepatocytes of pair fed ob/ob mice 
have both normal cristae structure and density. A total of 53 
micrographs from n=5 mice were studied and yielded similar results.
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Figure 24. Electron Microscopic Analysis of Hepatic Mitochondrial
Structure. Mitochondria in the hepatocytes of leptin treated ob/ob 
mice look less dense and “ballooned” compared to those from PBS 
treated (figure 22) and pair fed (figure 23) ob/ob mice. The cristae
structure also looks quite different in the leptin treated animals
compared to the other groups. A total of 51 micrographs from n=5 
mice in this group were studied and yielded similar results.
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day pair fed and 12-day PBS treated ob/ob mice.  The cristae structure was also 
different in the leptin infused group compared to the others. 
Having found structural differences in mitochondrial morphology and cristae 
structure with leptin treatment, we wanted to see if there were any differences in 
mitochondrial mass in the hepatocytes. Stereological assessment of these micrographs 
showed that hepatocytes from leptin treated ob/ob animals have a decreased 
mitochondrial numerical density of 1.57 mito/µm3 (Figure 25A), in comparison to 
2.55 and 2.99 mito/µm3 for saline treated and pair fed ob/ob animals respectively 
(p<0.01 for both comparisons). Furthermore, leptin treatment also decreases 
mitochondrial volume density in ob/ob mice to 0.154 µm3/µm3 (Figure 25B), 
compared to 0.245 and 0.281 µm3/µm  for saline treated and pair fed ob/ob controls 
respectively (p<0.05 for both). Leptin treatment, however, does not alter the average 
area of each individual mitochondrion with respect to saline treatment (0.90 vs 0.97 
µm2)(Figure 25C). On a side note, it appears that pair feeding increases individual 
hepatic mitochondrial size in comparison to both leptin treatment and saline infusion 
(p<0.05 for both). These data suggest that leptin treatment leaves each hepatocyte 
with fewer mitochondria of the same size, the implications of which are explored in 
more detail in the discussion section. 
Proteomic Changes Underlying Leptin’s Effects on the Liver 
We next set out to investigate whether changes in the levels of specific 
mitochondrial proteins were associated with the functional and morphologic changes 
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Figure 25. Electron Microscopic Analysis of Hepatic
Mitochondrial Morphology. Both mitochondrial numerical
density (A) and volume density (B) are decreased with leptin
treatment. Theaverage size of each mitochondria, however,
is unaffected by treatment with leptin (C). , = p < 0.01
, = p < 0.05
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that were observed.  Mitochondria from untreated ob/ob, leptin treated ob/ob, saline 
treated wt, and leptin treated wt mice were purified over a nycodenz gradient using a 
standard centrifugation protocol (see methods). The protein content of equal numbers 
of mitochondria was quantitated using the iTRAQ system. This method of protein 
measurement uses four isobaric tags with different reporters, which in tandem mass 
spectrometry allow one to accurately quantify differences as small as 10% among 
samples (Keshamouni et al., 2006). 
Three proteins that are components of the electron transport chain – 
cytochrome c oxidase subunit IV, cytochrome c oxidase subunit VIa, and 
mitochondrial NADH dehydrogenase – were significantly altered by changes in leptin 
levels (Figure 26). Protein levels of cytochrome c oxidase subunit IV showed no 
significant difference between ob/ob and wild-type mice, but were decreased to 
approximately 83% of their levels with leptin treatment in ob/obs (p<0.01). 
Cytochrome c oxidase subunit VIa protein levels, on the other hand, were found to be 
increased by 1.23 fold in ob/ob mice versus wild type mice (p<0.05), and leptin 
treatment of these ob/obs brought the level of these proteins down to 81% of their 
normal values (p<0.05). Finally, protein levels of mitochondrial NADH 
dehydrogenase were shown to be 1.53 fold higher in ob/ob mice versus wild-type 
mice (p<0.05), and were brought down to 77% of their normal values by leptin 
treatment in these ob/obs (p<0.05). The implications of the concerted increase in 
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ObPBS / 
WtPBS
ObLep / 
ObPBS Protein Name
Cellular
Location Function
No Change 2.43 Acyl-CoA thioesterase 2 (MTE1) Mito
1.32 1.52 Aldehyde dehydrogenase family 3, A2 ER
1.28 1.32 Medium-chain acyl-CoA dehydrogenase Mito
1.36 1.28 3-hydroxybutyrate dehydrogenase, type 1 Mito
1.34 1.25 Long-chain specific acyl-CoA dehydrogenase Mito
1.37 0.83 Glutaryl-CoA dehydrogenase Mito
No Change 0.83 Cytochrome c oxidase subunit IV isoform 1 Mito
1.29 0.83 3-hydroxyacyl-CoA dehydrogenase type II Mito
1.23 0.81 Cytochrome c oxidase subunit VIa polypeptide1 Mito
1.47 0.81 Acyl-CoA oxidase 1, palmitoyl Mito
1.35 0.81 Propionyl Coenzyme A carboxylase Mito
1.53 0.77 Mitochondrial NADH dehydrogenase 5 Mito
2.64 0.65 Acetyl-CoA acyltransferase 1B Mito Fatty acid metabolism. PPAR signaling pathway
1.47 0.58 Mito
3.49 0.53 ERELOVL family member 5, elongation of long 
chain fatty acids
Involved in long chain fatty acid elongation. 
Induction of Elovl-5 leads to massive hepatic 
accumulation of mono-unsaturated fatty acids
The first enzyme of the fatty acid beta-oxidation
pathway
Key enzyme in odd-chain fatty acid, isoleucine, 
threonine, methionine, and valine catabolism
NADH dehydrogenase. Complex 1 of 
mitochondrial respiratory chain
Solute carrier family 25 (mitochondrial carrier,
citrate transporter), member 1
Citrate-h+/malate exchange. Provides a carbon 
source for fatty acid and sterol biosyntheses, 
and nad+ for the glycolytic pathway.
Oxidative decarboxylation in degradation of L-
lysine, L-hydroxylysine, and L-tryptophan
Terminal enzyme of the mitochondrial 
respiratory chain
Catalyzes the oxidation of a wide variety of 
fatty acids, alcohols, and steroids
Terminal enzyme of the mitochondrial 
respiratory chain
Hydrolysis of acyl-coas to the free fatty acid 
and coenzyme a (coash)
Mitochondrial fatty acid beta-oxidation system; 
first step
Interconversion of the two major ketone bodies 
produced during fatty acid catabolism.
Mitochondrial fatty acid beta-oxidation system; 
first step
Aldehyde + NAD(+) + H(2)O = Fatty Acid + 
NADH
Figure 26. iTRAQ Protein Quantification of Hepatic Mitochondrial Proteins.  Three proteins that help comprise the electron transport 
chain – cytochrome c oxidase subunit IV, cytochrome c oxidase subunit VIa, and mitochondrial NADH dehydrogenase – are significantly 
altered by changes in leptin levels.  The increase in the abundance of these proteins during leptin deficiency and their decrease during 
leptin infusion may be the mechanism behind the observed differences in hepatic mitochondrial substrate oxidation described earlier.  
Also intriguing are the differences seen in the levels of the enzyme ELOVL5, which exhibited the highest increase in abundance during 
leptin deficiency, as well as the greatest decrease in abundance with leptin treatment.
 
these proteins during leptin deficiency and decrease with leptin treatment is explored 
in further detail in the discussion section. 
Another interesting protein that was found to vary with leptin levels was the 
enzyme ELOVL5, which had the highest increase in abundance during leptin 
deficiency, as well as the greatest decrease in abundance with leptin treatment (Figure 
26).  This enzyme is involved in long chain fatty acid elongation, and its induction 
has been shown to cause massive hepatic accumulation of mono-unsaturated fatty 
acids (Wang et al., 2006). ELOVL5 protein levels were increased by 3.49 fold in 
ob/ob mice versus wild-type mice (p<0.05), and leptin treatment of these ob/ob 
animals reduced the levels of this enzyme to 53% of its normal abundance (p<0.05). 
The implication of these changes in leptin-mediated correction of hepatic steatosis is 
explored in the discussion section. 
Leptin’s Effects on Hepatic Mitochondrial Lipids 
Having found significant changes in mitochondrial proteins induced by leptin, 
we next wanted to see if there were any changes in mitochondrial lipids brought about 
by the hormone. To do this we purified mitochondria using the same nycodenz 
gradient centrifugation protocol that was used for protein quantification in the 
previous section (see methods). Lipids were then eluted and separated by normal 
phase HPLC from the same number of mitochondria in each sample. The profile of 
lipid classes obtained by this method is shown in figure 27A. When tandem mass 
spectrometry (ms-ms) profiles were obtained from these lipids, it became clear that 
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Figure 27. Leptin-Mediated Changes in Hepatic Mitochondrial Cardiolipin Levels.
(A) Elution profile of lipid classes separated by normal phase-HPLC (B and C) 
Cardiolipin levels in hepatic mitochondria are much higher in ob/ob mice than in
wild-type mice, a difference that is corrected by leptin treatment. CL: cardiolipin, 
FA: Fatty Acid, PI: Phosphotidylinositol, PE: Phosphotidylethanolamine, 
PC: Phosphotidylcholine, SM: Sphigomyelin, LPC: lysophosphotidylcholine
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cardiolipin levels were much higher in ob/ob + PBS mitochondria than in wt + PBS 
mitochondria, and this difference was corrected by leptin treatment (Figure 27B). 
Indeed, quantification of the lipids showed that cardiolipin levels were more than four 
times higher in ob/ob mice than in wild-type mice (relative concentrations of 86 
versus 21)(Figure 27C). Leptin treatment brought down the lipid to a relative 
concentration of 11units. 
Leptin’s Effects on Hepatic Reactive Oxygen Species 
It has been shown that modifications of mitochondrial respiration can cause 
subsequent changes in reactive oxygen species (ROS) levels, both in vitro and in vivo 
(Ambrosio et al., 1993; Chance et al., 1979). Since our study found that leptin 
treatment of ob/ob mice alters mitochondrial substrate oxidation, we wanted to see 
what, if any, effects this may be having on the formation of ROS. Free radicals in 
vivo react with fatty acids and amino acids to form byproducts that can subsequently 
be measured to gain a sense of the ROS load in the tissue. To take a deeper look at the 
effects of leptin on ROS levels, we measured oxidated fatty acid (oxFA) levels from 
the livers of wild-type + saline, wild-type + leptin, ob/ob + saline, ob/ob + 2 days 
leptin, and ob/ob + 12 days leptin mice. The results were normalized in two ways and 
each of them shows a slightly different result. For the sake of thoroughness, I will 
present both findings in this section. 
In the first way of normalizing the measurements, the levels of oxFA are 
expressed as a ratio between the oxFA and its precursor (for example HETE / 
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arachidonic acid, or HODE / linoleic acid)  This normalization method probably 
results in the truest measurement of oxidative stress, as increased amounts of 
precursor will be associated with a proportional increase in the specific oxFA due to 
mass action. Since we are looking at the ratio of the oxFA and its precursor, 
differences in starting levels of precursor should be canceled out my employing this 
method of analysis. When analyzing the results in this method, we find that ob/ob 
mice have higher levels of nearly each of the twelve oxFA measured in liver tissue 
(Figure 28). Two days of leptin treatment seems to increase these levels slightly, 
whereas tweleve days of treatment with the hormone seems to increase oxFA levels 
even more. Though none of the differences observed are statistically significant as 
they stand, our collaborators believe that they will reach significance with the 
analysis of more samples. 
The second method of normalization involves dividing the measured levels of 
oxFA by the total mg of soluble protein in the liver homogenate. By conducting our 
analysis in this way we found that ob/ob mice had very low levels of the twelve oxFA 
measured in comparison to wild-type mice (Figure 29). Two days of leptin treatment 
partially raised oxFAs back to wild-type levels, and twelve days of treatment with the 
hormone pretty much restored wild-type levels for most of the oxFAs. Again, while 
none of the differences observed are statistically significant as they stand, our 
collaborators believe that they will reach significance with the analysis of more 
samples. 
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Figure 28. Oxidated Fatty Acids Normalized to their Precursors.  Initial trends suggest that ob/ob mice have higher amounts
of oxFA/precursor in liver homogenate than wild-type mice.  Leptin treatment of these ob/ob mice seems to increase the levels 
of oxidated fatty acids even further. Though none of the difference are statistically significant as they stand, our collaborators 
believe that they will reach significance with the analysis of more samples.
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Figure 29. Oxidated Fatty Acids Normalized to the Amount of Protein.  Initial trends suggest that ob/ob mice have lower amounts
of oxFA/mg soluable protein in liver homogenate than wild-type mice. Leptin treatment of these ob/ob mice restores the levels 
of oxidated fatty acids back to wild-type levels. Though none of the difference are statistically significant as they stand, ou
collaborators believe that they will reach significance with the analysis of more samples.
Leptin Affects Skeletal Muscle Mitochondrial Respiration 
Having completed our comprehensive study of leptin’s effects on hepatic 
mitochondria, we wanted to focus on other highly metabolic organs that are good 
candidates for leptin-mediated changes in energy expenditure. Skeletal muscle is 
another highly metabolic organ (Rolfe and Brand, 1996; Rolfe et al., 1999), which 
has been suggested to play a role in the increased energy expenditure associated with 
leptin treatment. For this reason we set out to measure mitochondrial respiration in 
this organ, specifically respiratory control ratio (RCR) and its components. 
RCR is a ratio that represents coupled respiration divided by uncoupled 
respiration. Twelve-day leptin treatment of ob/ob mice significantly reduces skeletal 
muscle mitochondrial RCR from 3.41 to 2.65 (Figure 30)(p<0.05). This change in 
RCR could be due to a decrease in the amount of coupled respiration, an increase in 
uncoupled respiration, or both. To explore these possibilities we measured state two, 
three, four, and FCCP rates next. Mitochondrial extraction from muscle gives a very 
poor yield, and thus five mice were pooled per sample. Each day we recorded from 
one sample of ob/ob + pbs mice and one sample of ob/ob + 12 day leptin treated 
mice. In order to correct for daily variances in electrode sensitivity - due to freshly 
made solutions, membrane permeability, electrode deposits, etc - we divided each of 
the recordings by the total amount of respiration recorded for that day. So ob pbs = ob 
pbs / (ob pbs + ob lep) ; ob lep = ob lep / (ob pbs + ob lep). This gave us a 
“normalized ratio” for each recording that we could compare from day to day. 
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Figure 30. Skeletal muscle mitochondria RCR analysis from ob/ob mice
plus/minus leptin. Twelve days of leptin treatment significantly reduces
respiratory control ratio (RCR) in the skeletal muscle of ob/ob mice. n=3 pooled
samples of 5 mice each, and every recording was done in duplicate. = p < 0.05
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State two and four rates give insight into mitochondrial leak, i.e. uncoupled 
respiration, and were both altered by leptin. Twelve-day leptin treatment significantly 
increased the skeletal muscle state two respiration normalized ratio from 0.45 to 0.55 
(Figure 31A)(p<0.01). This initially indicates that mitochondrial leak is increased in 
skeletal muscle by leptin, which would explain the decrease in RCR. However, when 
looking at state four respiration, we find that it is decreased by twelve-day leptin 
treatment from a normalized ratio of 0.55 to 0.45 (Figure 31B)(p<0.01). Further 
analysis regarding the meaning of these rates is carried out in the discussion section. 
Having explored uncoupled mitochondrial respiration in skeletal muscle, we 
next wanted to look at the numerator of RCR, namely coupled respiration. State three 
and FCCP rates provide a window into this and were thus recorded next. Twelve-days 
of leptin treatment reduced the skeletal muscle state three normalized ratio from 0.62 
to 0.38 (Figure 32A)(p<0.01). These results indicate that leptin may be decreasing the 
substrate oxidation system, like it does in liver tissue, and could help explain the 
changes we saw in RCR. However, though the differences are not yet statistically 
significant, further replicates may confirm the trend that FCCP rates are also higher 
with leptin treatment (Figure 32B), which would confound our interpretation of the 
state 3 rates. The meaning of these results is explored further in the discussion 
section. 
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Figure 31. Skeletal muscle leak analysis from ob/ob mice
plus/minus leptin. (A) State 2 rates are higher in ob/ob mice treated
with leptin, which initially suggested that a higher proton leak in this group
may be the cause behind the observed changes in the RCR. (B)
However, state 4 rates are lower in the leptin treated group, which make
the interpretation of the state 2 rates more complex. n=3 pooled samples
of 5 mice each, and every recording was done in duplicate. = p < 0.01
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Skeletal Muscle Mitochondrial Respiratory Capacity
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Figure 32. Skeletal muscle substrate oxidation analysis from
ob/ob mice plus/minus leptin. (A) State 3 rates are reduced with leptin
treatment of ob/ob mice. This suggests that leptin may be decreasing
the substrate oxidation system in skeletal muscle, which would be similar
to its effects in the liver. (B) However, though the differences are not yet
statistically significant, further replicates may confirm the trend that
FCCP rates are also higher with leptin treatment, which would confound
our interpretation of the state 3 rates. n=3 pooled samples of 5 mice
each, and every recording was done in duplicate. = p < 0.01
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Leptin Affects Heart Mitochondrial Respiration 
Another highly metabolic tissue that makes a good candidate for the site of 
leptin-mediated increases in energy expenditure is the heart. We therefore set out to 
measure mitochondrial respiration in this organ, again focusing on RCR and its 
components. Twelve-day leptin treatment of ob/ob mice lowers RCR in heart muscle 
from 3.02 to 2.08 (Figure 33)(p<0.05). Again, this change could be due to a reduction 
in coupled respiration, an increase in uncoupled respiration, or both. To gain insight 
into which of these possibilities is occurring in vivo, we measured state two, three, 
four, and FCCP rates next. Mitochondrial extraction from the heart, though not as 
tricky as that from skeletal muscle, also gives a very poor yield, as there is not much 
heart tissue in each animal. Thus we again pooled five mice per sample, and recorded 
from one group of ob/ob + pbs mice and one group of ob/ob + 12 day leptin treated 
mice per day. In order to correct for daily variances in electrode sensitivity, we again 
divided each of the recordings by the total amount of respiration recorded for that 
day, giving us a “normalized ratio” for each recording. 
To look at the uncoupled respiration component of RCR, we recorded state 
two and four rates next. Twelve-day leptin treatment significantly decreased heart 
mitochondrial state two normalized ratio from 0.57 to 0.43 (Figure 34A)(p<0.05). 
State four respiration rates, though not statistically different with the number of 
replicated performed, also show a trend to decrease with leptin treatment (Figure 
34B). Further interpretation of these rates is carried out in the discussion section. 
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Figure 33. Heart mitochondria RCR analysis from ob/ob mice plus/minus
leptin. Twelve days of leptin treatment significantly reduces respiratory control
ratio (RCR) in the heart muscle of ob/ob mice. n=3 pooled samples of 5 mice
each, and every recording was done in duplicate. = p < 0.05
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Figure 34. Heart leak analysis from ob/ob mice plus/minus
leptin. (A) State 2 rates are lower in ob/ob mice treated with leptin,
indicating that proton leak may be lower in the hearts of mice
receiving the hormone. (B) State 4 rates are unchanged with leptin
treatment. n=3 pooled samples of 5 mice each, and every
recording was done in duplicate. = p < 0.05
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Having explored uncoupled mitochondrial respiration in heart muscle, we next 
wanted to look at the coupled respiration component of RCR. Twelve-days of leptin 
treatment reduced the state three normalized ratio in heart mitochondria from 0.60 to 
0.40 (Figure 35A)(p<0.01). These results suggest that leptin may be decreasing the 
substrate oxidation system, as it does in liver tissue, and could help explain the 
changes seen in RCR. No difference was seen in FCCP rates between leptin treated 
and saline treated ob/ob mice (Figure 35B). 
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Figure 35. Heart substrate oxidation analysis from ob/ob mice
plus/minus leptin. (A) State 3 rates in heart mitochondria are reduced
with leptin treatment of ob/ob mice. This suggests that leptin may be
decreasing the substrate oxidation system in heart muscle, which would
be similar to its effects in the liver. (B) FCCP rates are unchanged with
leptin treatment. n=3 pooled samples of 5 mice each, and every
recording was done in duplicate. = p < 0.01
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 Chapter 4: Discussion 
Quantitation of Leptin’s Effects on Thermogenesis and Metabolism 
Body weight homeostasis is a fine balance between energy intake and 
expenditure (Spiegelman and Flier, 2001), which is innately controlled with an 
incredible amount of accuracy (Weigle, 1994). Obesity can only occur in the setting 
where energy intake exceeds energy expenditure, i.e. a state of positive energy 
balance, for a prolonged period of time. Any intervention that can tip the scale away 
from this positive energy balance, through either a reduction in caloric intake or an 
increase in energy expenditure, may be useful in combating obesity.  
While research on the treatment of obesity has focused heavily on the 
importance of food intake, several lines of evidence indicate that alterations of energy 
expenditure have a powerful, and perhaps dominant, effect on body weight 
(Friedman, 2004). Indeed, energy expenditure, basal metabolic rates and/or adaptive 
thermogenesis, are important variables that contribute to human obesity (Bouchard et 
al., 1990; Levine et al., 1999; Ravussin, 1995). For example, low energy expenditure 
is highly predictive of future weight gain (Ravussin et al., 1988b; Roberts et al., 
1988). Furthermore, weight loss in humans is met with a compensatory decrease in 
metabolic rate and increase in appetite, which work in concert to resist changes in 
weight (Leibel et al., 1995). These findings suggest that an understanding of the 
mechanisms behind changes in energy expenditure is key in combating obesity. Once 
such a foundation of knowledge has been established, we can work towards 
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pharmacological agents that mimic and augment the increase in resting metabolic rate 
induced by exercise. Such agents could be employed to counteract the compensatory 
metabolic decreases in response to weight loss discussed above, and may be valuable 
tools in our battle against morbid obesity (Friedman, 2004; Harper et al., 2001a; 
Lowell and Spiegelman, 2000). 
The ob gene product, leptin, is an adipocyte secreted negative feedback 
hormone that acts on the hypothalamus (Zhang et al., 1994). This hormone, a key 
regulator in body weight homeostasis, is known to decrease energy intake and 
increase energy expenditure to tip the scale towards negative energy balance 
(Campfield et al., 1995; Halaas et al., 1995; Pelleymounter et al., 1995). Ob/ob 
knockout mice lacking the hormone leptin have markedly reduced levels of energy 
expenditure, and become obese even when pair fed to littermate controls (Flier, 
2004b; Halaas et al., 1995). This and other studies have indicated that leptin’s effects 
on caloric intake in treated ob mice accounts for only half of the subsequent weight 
loss that is observed (Campfield et al., 1995; Collins et al., 1996; Halaas et al., 1995; 
Levin et al., 1996). This is because in addition to reducing caloric intake, leptin 
infusion of ob/ob mice increases total energy expenditure, selectively promotes fat 
metabolism, and prevents the fall in adaptive thermogenesis that normally occurs with 
reduced caloric intake (Doring et al., 1998; Halaas et al., 1997; Hwa et al., 1997; 
Kamohara et al., 1997; Mistry et al., 1997; Pelleymounter et al., 1995; Scarpace et al., 
1997; van Dijk et al., 1999).  
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After the ingestion of a meal, there is typically an adaptive thermogenesis 
response that tries to counteract any excess calories ingested. By adjusting for 
changes in physical activity, it has been shown that leptin infusion doubles the 
amount of feeding related adaptive thermogenesis by acting on both the amplitude 
and duration of it, and decreases postprandial RQ (Ruffin and Nicolaidis, 2000).  This 
conclusion is consistent with the finding that stimulation of the ventromedial 
hypothalamus (VMH), a brain center through which leptin exerts some of its 
catabolic effects, increases metabolism and decreases RQ (Ruffin and Nicolaidis, 
1999), while lesions in this area cause obesity (Elmquist et al., 1999a). Therefore, a 
significant portion of leptin-mediated weight loss can be attributed to an increase in 
energy expenditure, some of which, but not all, being attributable to adaptive 
thermogenesis. 
Much progress has been made in understanding leptin’s role in inducing 
satiety (Emond et al., 1999; Schwartz et al., 2000a) and the neural networks through 
which it triggers a rise in energy expenditure (Bachman et al., 2002; Elias et al., 
1998). However, little remains known about the downstream effector mechanisms by 
which the hormone increases energy expenditure, specifically adaptive thermogenesis 
(Spiegelman and Flier, 2001). In this report we tease apart the mechanisms through 
which leptin causes weight loss, demonstrate its effects on the mitochondrial structure 
and metabolism of three energy demanding organs, and delve into the underlying 
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kinetic and proteomic modifications to develop a deeper understanding of the 
observed changes. 
 Our results demonstrate that leptin-mediated weight loss is attributable to 
three major changes brought about by the hormone, namely its induction of satiety 
(Figure 9B, arrow 1), its correction of body temperature (arrow 2), and its activation 
of increases in energy expenditure and basal metabolic rate (arrow 3). The 
mechanisms underlying the anorexigenic effects of leptin were discussed earlier, and 
its correction of body temperature may be due to the hormone’s stimulation of 
sympathetic activity in brown fat (Collins et al., 1996; Haynes et al., 1997) and 
increase of UCP-1 mRNA and protein levels (Cusin et al., 1998; Satoh, 1998; 
Scarpace et al., 1997). Thus, for the remainder of our investigation we chose to 
explore the least understood of the changes brought about by leptin, i.e. the increase 
in energy expenditure and basal metabolic rate.  
Lepin-Mediated Changes in Liver Metabolism 
The liver is a major player in lipid homeostasis, and comprises a significant 
fraction of standard metabolic rate (Porter and Brand, 1993). It is also a known 
contributor to the catabolic effects of leptin (Cohen et al., 2002), and thus makes a 
good candidate for leptin-mediated increases in metabolic rate and adaptive 
thermogenesis. Our study into the livers of leptin deficient ob/ob mice showed that 
they are extremely steatotic, a finding that is corrected by twelve-day leptin treatment 
of the animals. Measurements of triglyceride levels in the livers of animals housed at 
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22oC or 30oC were able to show that the correction of steatosis by leptin is due to 
both normalization of body temperature by the hormone, and leptin-induced increases 
in energy expenditure and basal metabolic rate (Figure 10). These data suggest that 
part of the weight loss associated with leptin treatment is occurring in the liver. To 
study the leptin-induced increase in energy expenditure and basal metabolic rate in 
further detail, we wanted to take a closer look at hepatic metabolism during leptin 
treatment. 
Whole cell oxygen consumption recordings from freshly isolated primary 
hepatocytes using a Clarke electrode can be useful in identifying changes in the 
metabolic state of the liver (Brand et al., 1993; Harper and Brand, 1993; Porter and 
Brand, 1995; Porter, 2001; Schumacker et al., 1993), and were thus employed in our 
study. Significant differences were found in the basal metabolic rate, uncoupled 
respiration (i.e. leak), and non-mitochondrial respiration of primary hepatocytes 
isolated from saline treated and leptin treated ob/ob mice (Figure 11). However, 
contrary to what we were expecting, isolated primary hepatocytes from 12-day leptin 
infused mice had lower basal metabolic rates and non-mitochondrial respiration than 
those from saline infused mice (Figure 11A and C). The respiratory leak in 12-day 
leptin infused ob/ob mice was lower than of saline treated mice (Figure 11B), which 
is consistent with what has been reported previously (Melia et al., 1999). These data 
show that while the liver plays a definitive role in the change in energy expenditure 
and basal metabolic rate brought about by leptin, it may not be an effector organ for 
109
the increase in adaptive thermogenesis as we originally thought. To study these 
leptin-induced changes in hepatocyte energy expenditure in further detail, we went on 
to look at liver mitochondrial metabolism. 
 Measurement of the components of mitochondrial respiration has proven to be 
useful in identifying the changes underlying differences in metabolic rates (Brand et 
al., 1999; Brand et al., 1994; Brown et al., 1990; St-Pierre et al., 2003). Modular 
kinetic analysis conducted alongside such measurements allows one to gain further 
insight into the kinetic properties mitochondrial leak, substrate oxidation, and the 
phosphorylation system (Brand et al., 1993; Hafner et al., 1990; Porter and Brand, 
1995). To further investigate the possibility of mitochondrial metabolic changes in the 
liver brought about by leptin, we both measured the different components of hepatic 
mitochondrial respiration, and conducted modular kinetic analysis.  
Our results demonstrate that leptin increases the respiratory control ratio 
(RCR) of liver mitochondria in ob/ob mice (Figure 12). This indicates that hepatic 
mitochondrial respiration is more coupled in mice receiving leptin, a phenomenon 
that is the opposite of what we expected to see. State two and four rates decrease with 
leptin treatment as well (Figure 13), which one may interpret as an indication that 
mitochondrial leak is decreasing. If this were the case, the decreased leak with leptin 
treatment would explain the increased RCR, as the leak rate is the denominator of the 
RCR ratio. However, we find that FCCP rates also decrease with leptin treatment 
(Figure 14), which indicates that the hormone is suppressing the substrate oxidation 
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system. A decrease in substrate oxidation would cause a subsequent decrease in the 
proton gradient across the inner mitochondrial membrane, which would reduce the 
electro-chemical driving force for proton leak. Similarly, a decrease in proton leak 
would cause a subsequent increase in the proton gradient across the inner 
mitochondrial membrane, which would increase the resistance against which the 
substrate oxidation system has to pump protons. These findings raise the proverbial 
“chicken or egg” question, i.e. is the decreased proton leak leading to a decrease in 
the substrate oxidation system, or vice versa. To settle this issue we turned to modular 
kinetic analysis, which measures both leak and substrate oxidation as a function of 
mitochondrial inner membrane potential, and thus allows us to measure each rate 
without the confounding effects of the other. 
In modular kinetic analysis, one dissipates the mitochondrial inner membrane 
potential in a stepwise fashion and concurrently uses different assortments of 
mitochondrial inhibitors to measure the kinetics of the substrate oxidation system, 
phosphorylation system, and proton leak (Brand et al., 1993; Hafner et al., 1990; 
Porter and Brand, 1995). Conducting these measurements in ob/ob and wild-type 
mice treated with both leptin and pbs revealed that the leptin-mediated changes in 
liver mitochondrial metabolism are due to the hormones effect on the substrate 
oxidation system (Figure 17). Leak and phosphorylation system kinetics were not 
altered by lepin (Figure 18), and the changes in leak rates seen earlier were secondary 
to the effects of the substrate oxidation system on the mitochondrial inner membrane 
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potential. The reason differences in leak rates emerged is because leak in ob/ob + pbs 
mice is more sensitive to changes in inner membrane potential than it is in ob/ob + 
lep, wt + pbs, or wt + lep mice. This can been seen on in figure 18A, where at higher 
membrane potentials, the leak increases much more in the ob/ob + pbs mice than it 
does in any of the other groups. 
In light of these observations, one wonders if the observed change in substrate 
oxidation kinetics is a secondary response to the hepatic steatosis exhibited by ob/ob 
mice, attempting to increase oxidative phosphorylation rates in the face of 
compromised fatty acid oxidation. Induction of hypo-leptinemia in wt mice is an 
innovative way to distinguish between the direct effects of leptin, and those that are 
secondary to its correction of hepatic steatosis (Montez et al., 2005). Employing this 
method, we show that state two and four respiration rates aren’t affected in 
hypoleptinemic wt mice (Figure 20). This suggests that leptin levels don’t influence 
mitochondrial leak, a finding that is consistent with what was seen in ob/ob mice 
using modular kinetic analysis. Furthermore, FCCP rates are higher in 
hypoleptinemic mice (Figre 21), indicating that leptin levels affect the substrate 
oxidation system, which is also consistent with findings in ob/ob mice. Since the 
metabolic changes during leptin deficiency and restoration are the same in the 
presence or absence of hepatic steatosis, we can conclude that leptin’s control over 
the hepatic mitochondrial substrate oxidation system is independent of its effects on 
hepatic fat stores. 
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Leptin’s Influence Over Hepatic Mitochondrial Structure 
There is a positive correlation between the metabolic activity of a tissue and 
the morphologic features of the mitochondria in that tissue - such as size, volume 
density, and cristae structure (Ghadially, 1988). Furthermore, studies of adaptive 
thermogenesis have shown oxygen consumption to be correlated with cristae length 
and density (Martin et al., 1999; Rodriguez-Cuenca et al., 2002). Having observed 
changes in liver mitochondrial metabolism with leptin treatment, we wanted to 
measure mitochondria morphology to see if it was affected as well.  
Our electron micrographic investigation of ob/ob livers reveals that leptin 
treatment of these mice causes a change in mitochondrial appearance and cristae 
structure (Figures 22-24). Though leptin does not change individual mitochondrion 
size, it significantly decreases the numerical and volume density of hepatic 
mitochondria in ob/ob mice (Figure 25). We also know from modular kinetic analysis 
that the mitochondria from leptin treated ob/ob mice have a suppressed substrate 
oxidation system. This reduction in mitochondrial volume alongside the suppression 
of the substrate oxidation system, could explain the previously discussed decrease in 
hepatocyte basal metabolic rate brought about by the hormone. Therefore, the 
structural data give an indication that both volumetric and metabolic differences in 
these hepatic mitochondria may be contributing to the changes observed in the liver. 
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Leptin’s Influence Over the Hepatic Mitochondrial Mileu 
Leptin has an extensive range of effects that take shape through its influence 
over numerous molecular pathways (Flier, 2004b; Friedman, 1998). To circumvent 
the difficulty in identifying which of these pathways exert leptin’s influence over 
substrate oxidation, we purified mitochondria and measured their protein content in 
ob/ob and wild-type mice after 12 days of treatment with either leptin or saline. 
Interestingly, we found that three components of the electron transport chain were 
significantly increased in abundance during leptin deficiency, and decreased during 
leptin infusion (Figure 26). These were cytochrome c oxidase subunit IV, cytochrome 
c oxidase subunit VIa, and mitochondrial NADH dehydrogenase. Leptin’s influence 
over the protein levels of these mitochondrial respiratory chain components may be 
the mechanism by which it causes the observed differences in substrate oxidation 
described earlier. 
Also interesting to note were the changes in protein levels of the long chain 
fatty acid elongase ELOVL5, which were drastically increased in abundance in ob/ob 
mice as compared to wild-type littermates, and were significantly decreased with 
leptin treatment of these ob/obs (Figure 26). The induction of this enzyme has been 
shown to cause massive hepatic accumulation of mono-unsaturated fatty acids (Wang 
et al., 2006). Perhaps the low level of this enzyme in leptin deficiency is underlying 
the hepatic steatosis observed in ob/ob animals, and its increase with leptin infusion 
leads to the correction of this state. 
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Changes in mitochondrial lipid levels can affect mitochondrial function, and 
more importantly changes in mitochondrial metabolism can influence the lipid 
composition of the organelle (Ball and Joel, 1962; Paradies et al., 1999; Paradies and 
Ruggiero, 1991; Senault et al., 1990). Furthermore, in both diabetes and insulin 
treatment of the disorder, there are changes induced in the lipid/phospholipid 
composition of mitochondria (Patel and Katyare, 2006). Having found that leptin 
affects the mitochondrial substrate oxidation system in a way to decrease 
mitochondrial metabolism, we wanted to see if we could identify corresponding 
changes in mitochondrial lipids induced by the hormone. Using mass spectrometry, 
we were able to show that cardiolipin levels are significantly higher in ob/ob mice 
than in wild-type mice, a difference that was diminished by leptin treatment (Figure 
27). Interestingly, cardiolipin interacts with the mitochondrial respiratory chain and 
can change the efficiency of oxidative phosphorylation (Gohil et al., 2004; Hatch and 
McClarty, 1998; Hoch, 1992; Hoch, 1998; Koshkin and Greenberg, 2000). Perhaps 
changes in cardiolipin are relevant to the lepin-induced changes in mitochondrial 
metabolism. 
In addition to affecting the lipid composition of mitochondria, changes in 
mitochondrial metabolism can influence free-radical production in the organelle 
(Andrews et al., 2005). Studies have documented increased oxidative stress in obese 
individuals and have noted its impact on the metabolic syndrome (Furukawa et al., 
2004; Keaney et al., 2003). Indeed, many studies argue that oxidative stress and the 
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signaling pathways it activates are mediators of insulin resistence and beta cell 
dysfunction in type 2 diabetes (Evans et al., 2002; Evans et al., 2003; Kelley et al., 
2002; Schrauwen and Hesselink, 2004). Some go on to link central obesity as a cause 
of the oxidative stress that subsequently leads to atherosclerosis, endothelial 
dysfunction, and beta cell failure (Bakker et al., 2000; Perticone et al., 2001). 
The mitochondrial electron transport chain is the main producer of reactive 
oxygen species (ROS) in most cells (St-Pierre et al., 2006). Since we found leptin to 
have metabolic, proteomic, and lipidomic effects on the electron transport chain of 
hepatocytes, we wanted to see if this caused a subsequent change in ROS production. 
To take a deeper look at the effects of leptin on ROS levels, we measured oxidated 
fatty acid (oxFA) levels from the livers of wild-type + saline, wild-type + leptin, 
ob/ob + saline, ob/ob + 2 days leptin, and ob/ob + 12 days leptin mice. Our studies 
found a trend of increased oxFA with leptin treatment (Figures 28 and 29). While 
these trends are not statistically significant as they stand, our collaborator recording 
the oxFA levels is confident that they will be with further replicates. Such data would 
fit in well with previous findings that leptin induces oxidative stress in a variety of 
organisms (Beltowski et al., 2003; Bouloumie et al., 1999; Yamagishi et al., 2001). 
Lepin’s Effects on Skeletal Muscle and Heart Metabolism 
 Calorimetric studies have shown leptin to increase whole body oxygen 
consumption in ob/ob mice (Campfield et al., 1995; Halaas et al., 1997; Halaas et al., 
1995; Pelleymounter et al., 1995). However, our measurements show that the 
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hormone decreases basal metabolic rate in hepatocytes and inhibits the substrate 
oxidation system in hepatic mitochondria. In order for both observations to be correct, 
there must be other organs in which leptin increases energy expenditure. The heart 
and skeletal muscle comprise a significant fraction of standard metabolic rate (Rolfe 
and Brand, 1996; Rolfe et al., 1999), and thus make good candidates for other tissues 
upon which leptin may be exerting its metabolic effects. To measure the effects of 
leptin on these tissues we measured the different components of mitochondrial 
respiration from ob/ob mice treated with either leptin or saline for twelve days. 
Our results show that, opposite to its effects in the liver, leptin significantly 
decreases respiratory control ratio (RCR) in skeletal muscle (Figure 30). To explore 
the cause(s) behind this change, we took a further look at mitochondrial leak and 
coupled respiration, the two components of RCR. State two rates were found to be 
higher with leptin treatment (Figure 31A), which initially indicated that mitochondrial 
leak might be increased in animals receiving the hormone. This could help explain the 
lower RCR, as mitochondrial leak is the denominator in the RCR ratio. However, we 
also observed that state four respiration is decreased with leptin treatment (Figure 
31B), which would suggest that mitochondrial leak is decreased. The conflicting state 
two and four findings confound our analysis of uncoupled respiration and do not 
allow us to come up with a definitive conclusion regarding changes to mitochondrial 
leak. To resolve this issue, one would have to do modular kinetic analysis using a 
TPMP electrode. 
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A similar situation arises with state three and FCCP rates in skeletal muscle 
mitochondria. Leptin treatment significantly lowers state three rates (Figure 32A), 
which indicates that the hormone may decrease coupled respiration. This would also 
explain the changes to RCR, as coupled respiration is the numerator in the RCR ratio. 
However, though they are not statistically significant as they stand, FCCP rates show 
a nearly significant trend of increasing with leptin treatment (Figure 32B). Perhaps 
further replicates of this recording would bring the trend to significance, in which 
case there would be a conflict regarding the interpretation of coupled respiration. 
Once again, modular kinetic analysis using a TPMP electrode could be employed to 
resolve the issue. 
Turning our attention to heart mitochondria, we find that twelve days of leptin 
treatment also decreases the RCR in this tissue (Figure 33). To explore the cause(s) 
behind this change, we again took a further look at mitochondrial leak and coupled 
respiration. State two and four rates are reduced with leptin treatment (Figure 34), 
which indicates that mitochondrial leak may be decreased in the hearts of mice 
receiving the hormone. At the same time state three rates are decreased with leptin 
treatment as well (Figure 35), which suggests that substrate oxidation may be reduced 
in the hearts of leptin treated ob/ob animals. This raises the proverbial chicken and 
egg question once more. Is the decreased leak causing a buildup of the proton 
gradient, and thus slowing substrate oxidation rates by forcing the mitochondrial 
respiratory chain to pump against a higher eletro-checmical force? On the other hand, 
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are decreased substrate oxidation rates resulting in a smaller mitochondrial inner 
membrane proton gradient, causing subsequent decreases in proton leak rates? To 
answer these questions, one could conduct modular kinetic analysis on isolated heart 
mitochondria. 
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 Conclusion 
 The primary goal of the work described here was to gain a better 
understanding of the cellular and molecular mechanisms underlying leptin’s 
metabolic effects. The experiments in this thesis start off by identifying the three 
different ways in which leptin causes weight loss, namely the induction of satiety, the 
normalization of body temperature, and the increase of energy expenditure and basal 
metabolic rate. They then go on to take an in depth look at the liver, skeletal muscle 
and heart, which we felt were three strong candidate organs for involvement in the 
leptin mediated increase of energy expenditure. 
We report that leptin treatment of ob/ob mice reduces the basal metabolic rate, 
uncoupled respiration (i.e. leak), and non-mitochondrial respiration of primary 
hepatocytes. By recording the components of mitochondrial respiration and 
conducting modular kinetic analysis, we show that leptin treatment of ob/ob mice 
decreases the substrate oxidation system in the liver. In vivo withdrawal studies show 
that these changes are directly caused by leptin, and are not downstream of the 
hormone’s correction of hepatic steatosis. Furthermore, electron microscopy and 
morphometry studies reveal that in addition to causing metabolic changes in 
mitochondria, leptin treatment changes mitochondrial structure, size, and volume 
density in the liver. Thus we are able to provide both a metabolic and structural basis 
for our observed effects of leptin on hepatocytes. 
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We next wanted to see if we could find the proteomic and lipidomic changes 
underlying the metabolic and structural changes discussed above. Proteomic analysis 
using iTRAQ tandem mass spectrometry quantification revealed that leptin-mediated 
changes in three components of the mitochondrial respiratory chain could account for 
the aforementioned metabolic effects of leptin in the liver. It also showed that drastic 
changes in levels of the enzyme ELOVL5 might be responsible for the hepatic 
steatosis exhibited with leptin deficiency, and for its correction with leptin treatment. 
Furthermore, mass spectrometry showed differences in mitochondrial cardiolipin 
levels that are associated with the observed leptin-mediated changes in the liver. 
Finally, our measurements of oxidated fatty acids show a trend that leptin may be 
altering the levels of reactive oxygen species in hepatic mitochondria. Thus we are 
able to provide a proteomic and lipidomic basis for our observed effects of leptin on 
liver mitochondrial metabolism and hepatic steatosis, and show additional effects of 
the hormone on the mitochondrial milieu. 
Having completed a thorough investigation into leptin-mediated changes in 
the liver, we moved on to the other two candidate organs, the heart and skeletal 
muscle. Our findings show that the respiratory control ratio (RCR) is reduced in 
mitochondria isolated from both the heart and skeletal muscle of mice treated with 
leptin for 12 days. In skeletal muscle, state two and four recordings are somewhat 
conflicting about leptin-mediated changes in mitochondrial leak, and state three and 
FCCP rates are somewhat conflicting about changes in coupled respiration. The 
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mitochondrial rates paint a clearer picture in the heart, showing that both leak and 
coupled respiration are decreased with leptin treatment. However, it is likely that 
there is interplay between these rates, and one cannot say which is influencing the 
other. To resolve both this issue and the conflicts in interpretation of skeletal muscle 
rates, one needs to conduct modular kinetic analysis. Thus, our results show that 
leptin clearly modulates mitochondrial respiration in the heart and skeletal muscle, 
though we cannot yet say exactly how it does so. 
In conclusion, our analysis of the liver shows that leptin decreases 
mitochondrial substrate oxidation and volume density, leading to a resultant decrease 
in hepatocyte basal metabolic rate. It does so by changing levels of three proteins in 
the mitochondrial respiratory chain. These effects are a direct result of leptin and not 
secondary to its correction of hepatic steatosis, which is likely occurring through its 
influence on the fatty acid elongase ELOVL5. We also clearly show that skeletal 
muscle and heart metabolism are changed with leptin treatment, and lay the 
foundation for future work on these tissues. These observations advance our 
understanding of the catabolic effects of leptin, and bring us one step closer to 
coming up with potential therapeutic treatments for obesity that approach the problem 
from a completely new angle. 
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